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Abstract 
 
 
Dehalogenimonas lykanthroporepellens BL-DC-9
T
 is an anaerobic bacterial strain that 
can reductively dehalogenate a variety of vicinally chlorinated alkanes. Making use of the 
strain’s genome sequence, PCR primers were designed to uniquely target each of the 25 
reductive dehalogenase homologous (rdhA) genes present in the genome. RNA extracted from D. 
lykanthroporepellens BL-DC-9
T
 cultures that were dechlorinating three chlorinated solvents 
(1,2-dichloroethane, 1,2-dichloropropane and 1,2,3-trichloropropane) were used in reverse 
transcriptase PCR (RT-PCR) to determine rdhA gene expression patterns. Transcripts from 19 
rdhA genes were detected in the RT-PCR experiments, with identical gene expression patterns 
during growth with all three chlorinated electron acceptors employed in the study. The 
transcripts included thirteen full-length rdhA genes, six truncated rdhA genes, and five rdhA 
genes having a cognate rdhB gene. Transcripts from four putative transcriptional regulators were 
also detected during organohalide respiration with 1,2-dichloroethane, 1,2-dichloropropane and 
1,2,3-trichloropropane, providing insights in the regulatory controls on rdhA gene expression. 
A dehalogenase enzyme assay was developed, and attempts were made to heterologously 
express the rdhA gene with locus tag Dehly_1524 (recently identified as encoding a 1,2-
dichloropropane reductive dehalogenase) in Escherichia coli. The majority of the heterologously 
expressed protein was found in the insoluble fraction and in a catalytically inactive form under 
all conditions tested; this was inferred to be due to the absence of de novo cobamide synthesis in 
E. coli and the requirement for this cofactor for enzymatic activity. 
Functional expression of the Dehly_1524 protein was also attempted under anoxic 
conditions using the cobamide producing species Shimwellia blattae that was recently identified 
 ix 
 
as having a genetic system that allowed the functional expression of dehalogenases from another 
species (Desulfitobacterium hafniense strains Y51 and DCB-2). The Dehly_1524 protein was not 
catalytically active when expressed in Shimwellia blattae under the conditions tested, however, 
indicating that Shimwellia blattae may not contain a genetic system broadly suitable for 
functional expression of the growing number of putative reductive dehalogenase genes available 
in the public databases.………………………………………………………………………….
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Chapter 1. Introduction and literature review 
 
1.1 Introduction 
 
Dehalogenimonas lykanthroporepellens strain BL-DC-9
T
 was first isolated from 
contaminated groundwater at the PetroProcessors of Louisiana, Inc. Superfund site located near 
Baton Rouge, LA (USA). This species is of particular interest because of its unique ability to 
reductively dehalogenate a variety of vicinally chlorinated aliphatic alkanes including 1,2-
dichloroethane (1,2-DCA), 1,2-dichloropropane (1,2-DCP), 1,1,2,2-tetrachloroethane (1,1,2,2-
TeCA), 1,1,2-trichloroethane (1,1,2-TCA), and 1,2,3-trichloropropane (1,2,3-TCP) via 
dihaloelimination reactions (Moe et al., 2009; Yan et al., 2009). The recently sequenced genome 
of D. lykanthroporepellens strain BL-DC-9
T
 (GenBank accession no. CP002084) contains 25 
loci having reductive dehalogenase homologous (rdh) genes scattered throughout the 
chromosome (Siddaramappa et al., 2012). Prior to the research presented in this dissertation, the 
expression pattern of these rdh genes during reductive dechlorination was unknown. Research 
presented in this dissertation was aimed at determining the pattern of rdh gene expression during 
dechlorination of three substrates: 1,2-dichloroethane (1,2-DCA), 1,2-dichloropropane (1,2-
DCP), and 1,2,3-trichloropropane (1,2,3-TCP). Efforts were also made to heterologously express 
a functional reductive dehalogenase enzyme using two different bacterial hosts.  
1.2 Dissertation Organization 
Chapter 1 of this dissertation presents a literature review focused on the characteristics of 
dehalogenase enzymes, previous transcriptomic studies of dehalogenating bacteria, and 
heterologous expression of dehalogenase enzymes. Chapter 2 describes experiments that 
employed reverse-transcriptase PCR (RT-PCR) to study the pattern of reductive dehalogenase 
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gene expression during the dechlorination 1,2-dichloroethane (1,2-DCA), 1,2-dichloropropane 
(1,2-DCP), and 1,2,3-trichloropropane (1,2,3-TCP). It also includes results from experiments 
conducted to determine gene expression patterns of the transcription factors that are associated 
with a subset of reductive dehalogenase genes in Dehalogenimonas lykanthroporepellens strain 
BL-DC-9
T
. Chapter 3 presents results from experiments aimed at expression of a functional 
reductive dehalogenase protein in Escherichia coli. Chapter 4 presents the results from 
experiments aimed at functional expression of the reductive dehalogenase protein in a cobamide 
producing Shimwellia blattae strain. Chapter 5 presents a summary of the major findings from 
the research and recommendations for future work.  
1.3 History and overview 
Reductive dehalogenation is a bioremediation process in which microbes capable of 
transforming toxic xenobiotic compounds are exploited for biodegradation of environmental 
pollutants and industrial wastes (Holliger et al., 1999). Anaerobic bacterial strains have been 
identified that use the polychlorinated solvents as electron acceptors and derive energy from 
reductive reactions. This process in which anaerobic bacterial strains derive energy from this 
process has been alternatively referred to in the literature as dehalorespiration or organohalide 
respiration. The enzymes that bring about the anaerobic transformation are referred to as 
reductive dehalogenases (Holliger et al., 2003).  
Polychlorinated alkanes are some of the most common groundwater contaminants in the 
United States and throughout the world (Löffler and Edwards, 2006). Many are known or 
suspected to cause adverse health effects, with several belonging to the category of suspected 
carcinogens (De Wildeman and Verstraete, 2003).  
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D. lykanthroporepellens strain BL-DC-9
T
 has been reported to dechlorinate a number of 
polychlorinated alkanes. It dechlorinates 1,2-dichloroethane to the non-toxic, non-halogenated 
final product ethene. Similarly, it has been shown to dechlorinate 1,2-dichloropropane to the 
non-chlorinated, non-toxic product propene. It is also one of the few strains isolated to date that 
can anaerobically dechlorinate 1,2,3-trichloropropane, forming allyl chloride (3-chloro-1-
propene), which is relatively unstable and can undergo a variety of abiotic reactions to produce a 
variety of products includig allyl alcohol (Moe et al., 2009; Yan et al., 2009). 
Tetrachloroethene (PCE) has been found to be dechlorinated to trichloroethene (TCE) by 
bacterial strains having the pceA gene, which codes for proteins capable of dechlorination of 
PCE. The ε-proteobacterium Sulfurospirillum multivorans strain K performs the dechlorination 
of PCE (Neumann et al., 1998). Dehalobacter restrictus strain PER-K23, Desulfitobacterium 
hafniense strain TCE1, D. hafniense strain PCE-S and Desulfitobacterium sp. Strain Y51 are also 
reported to have the pceA gene, which codes for the protein capable of dechlorinating PCE 
(Maillard et al., 2003). The pceA gene has also been reported in Dehalococcoides mccartyi strain 
195 (Magnuson et al., 2000). 
Representatives of the species D. mccartyi are able to dechlorinate a variety of 
halogenated pollutants including chlorobenzenes and chlorinated ethenes. Of particular 
significance in the environmental field, representatives of this species are the only strains thus far 
isolated in pure culture with an ability to anaerobically dehalogenate the carcinogen vinyl 
chloride (Löffler et al., 2013). Interestingly, while D. mccartyi strains appear to be obligate 
organohalide respirers not known to grow using electron acceptors other than halogenated 
organics, the various isolates obtained in pure culture to date vary with respect to which 
chlorinated compounds they dehalogenate. For example, D. mccartyi strain CBDB1 
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dechlorinates chlorobenzenes and dibenzodioxin congeners. D. mccartyi strains 195 and FL2 
dechlorinates polychlorinated ethenes, and D. mccartyi strain BAV1 is capable of 
dehalogenating DCE and vinyl chloride (Cupples et al., 2003; He et al., 2003; Maymó-Gatell et 
al., 1997, Maymó-Gatell et al., 2001). 
Presently, there are more than 650 reductive dehalogenase homologous (rdh) gene 
sequences available in the public databases. The functions of only a few of them, however, are 
known (Tang et al., 2012). Extreme oxygen sensitivity and slow growth of the organisms make 
the characterization of these genes and the proteins that they encode difficult. Although a genetic 
system for expression of functional reductive dehalogenase has recently been identified, 
production of functional reductive dehalogenases still remains challenging (Mac Nelly et al., 
2014). 
1.4 Reductive dehalogenase enzyme characteristics 
At the genetic level, reductive dehalogenase proteins have been classified into three 
types. Most of the proteins characterized to date have the unique similarity of possessing two 
iron-sulfur clusters along with a corrinoid cofactor (Holliger et al., 2003). At the amino-terminal 
end, the proteins are characterized by a conserved twin-arginine transport system (TAT) signal 
sequence that is thought to aid in the export of periplasmic proteins (Berks et al., 2000). The 
second type of protein is characterized by the absence of iron sulfur cluster and the presence of 
one corrinoid cofactor. Examples for this class of proteins include the ortho-chlorophenol 
dehalogenase from Desulfitobacterium frappieri PCP-1 (Boyer, 2003) and the PCE reductive 
dehalogenase that was originally attributed to Clostridium bifermentans DPH-1 (Okeke, 2001), a 
culture that was later determined to include two populations, a Clostridum sp. and 
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tetrachloroethene-dechlorinating Desulfitobacterium hafniense strain JH1 (Fletcher et al. 2008). 
The third type of protein is totally different from the first two types and is a heme protein having 
two subunits. This protein is unique to the chlorobenzoate dehalogenase of Desulfomonile tiedjei 
(Ni et al., 1995). For the small number of reductive dehalogenases that have been functionally 
characterized to date, the genes are organized in the form of an operon. For example, the genes 
encoding tetrachloroethene reductive dehalogenase (pceA) and trichloroethene reductive 
dehalogenase (tceA) are closely linked to genes pceB and tceB. These latter genes (i.e., pceB and 
tceB) are thought to code for hydrophobic proteins that acts as membrane anchors for the 
reductive dehalogenases and are transcribed along with the first part (i.e., pceA and pceB are co-
transcribed) (Villemur et al., 2002). 
If a “full-length” rdhA is predicted to encode a protein containing a twin-arginine 
sequence at the N-terminus, two iron-sulfur cluster binding motifs at the C-terminus, and an 
intervening sequence of ~450-500 amino acids, then D. lykanthroporepellens BL-DC-9
T
 contains 
17 such genes (Siddaramappa et al., 2012). Eight other rdhA genes in the genome appear to be 
substantially truncated and are predicted to encode proteins lacking the N-terminus, C-terminus, 
or both (Table S1). Only six of the rdhA ORFs have a cognate rdhB, and an additional rdhB gene 
(Dehly_1504) appears to be an orphan with no cognate rdhA ORF nearby (Siddaramappa et al., 
2012) 
1.5 [Fe-S] Clusters functional significance 
 
As mentioned earlier in this chapter, reductive dehalogenase enzymes belong to a class of 
enzymes that have iron sulfur clusters. Iron-sulfur cluster binding proteins are a family of 
proteins that have Fe and S as cofactors and are involved in electron transfer pathways in redox 
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reactions (Rao et al., 2004). It is recurringly observed in [Fe-S] cluster binding proteins, that the 
iron element is liganded by a number of cysteine residues, and these families of proteins are 
widespread in a large number of biological samples (Gorst et al., 1995). They have also been 
detected in anaerobic bacteria through electron paramagnetic resonance signals (Shethna et al., 
1964). Detection of electron paramagnetic signals is the most frequent way of confirming the 
presence of [Fe-S] clusters in proteins although a combination of multiple spectroscopic methods 
(e.g., UV spectroscopy) are generally the procedure for the detection of [Fe-S] clusters (Lill et 
al., 2006).  
The [Fe-S] clusters function in mediating a single electron transfer process in bacterial 
cells. A specific example of an iron sulfur binding protein is the [3Fe-4S] bacterial enzyme 
Ferrodoxin I (Johnson et al., 2005). The [Fe-S] binding proteins mediate oxidation-reduction 
reactions by switching between the different oxidized and reduced forms. Rhombic [2Fe-2S], for 
example, can carry out the redox reactions by interchanging between the oxidized form [2Fe-
2S]
2+ 
to the reduced form [2Fe-2S]
+
 (Rao et al.,2004). In a similar manner, Cubane [4Fe-4S] 
mediates redox reactions by existing in three different oxidation states: [4Fe-4S]
+
, [4Fe-4S]
2+
, 
and [4Fe-4S]
3+
 (Rao et al., 2004).
. 
Although a large number of [Fe-S] binding proteins have been 
identified, a clear binding motif for binding of [Fe-S] has yet to be identified. Some of the 
common structural residues for the identification of [Fe-S] cluster proteins are the residues 
CX4CX2CX30C in ferredoxins and the residue CX2CX2CX20-40C for [4Fe-4S] (Lill et al., 2006). 
Chemical reconstitution of a number of functionally inactive [Fe-S] binding proteins have 
resulted in catalytically active proteins, and several [Fe-S] biogenesis pathways and genes 
involved in [Fe-S] biogenesis has been identified in prokaryotes  (Malkin et al., 1966, Barras et 
al., 2005). 
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1.6 Overview of catalysis by cobalamine dependent enzymes 
 
1.6.1 Structure 
Cobalamines are some of the chemical forms of Vitamin B12 and are found in different 
conformations in B12 dependent enzymes. Cobalamines found in B12 dependent enzymes contain 
a central cobalt atom that is liganded with four nitrogen atoms from the pyrroles of the corrin 
ring (Fig 1.1). The upper ligand attached to the cobalt atom is deoxyadenosine in the case of 
adenosine cobalamine, methyl in methylcobalamin, hydroxy in hydroxocobalamin and 
cyanocobalamin in vitamin B12 (Figure 1.1). The lower ligand attached to the cobalt varies for 
different organisms, and the most commonly occurring lower ligand for cobalamines is the 
endogenous base dimethylbenzimidazole (Fig 1.1). At physiological pH, the lower ligand 
generally exists as a base on confirmation; however, it can also exist as a base off conformation 
when the lower base is protonated. In some instances, the dimethylbenzimidazole can be 
replaced by a histidine residue from the protein, which attaches to the corrin ring (Brown et al., 
1984; Mancia et al., 1986). Tight binding to the associated protein is achieved by hydrogen bond 
formations between the regulated protein and the peripheral side chains of the corrin ring 
(Banerjee and Ragsdale, 2003). 
Vitamin B12 is a family of organometallic cofactors that are known to regulate different 
enzymes such as isomerases, methyltransferases, and more recently, dehalogenases. The role of 
vitamin B12 in the catalytic activity by isomerases and methyltransferases has been well studied, 
while their role in free radical reactions in dehalogenases is not yet completely elucidated 
(Banerjee and Ragsdale, 2003). 
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Figure 1.1 General structure of the cobalamine found in vitamin B12 dependent enzymes.  R is the 
upper ligand attached to the cobalt atom (Reprinted with permission from Banerjee and 
Ragsdale, 2003). The upper ligand is deoxyadenosine in case of adenosinecobalamine, methyl in 
methylcobalamine, hydroxy in hydroxocobalamine and cyanocobalamine in vitamin B12. The 
lower ligand dimethylbenzimidazole can exist as base on confirmation (Dmb-on), base off 
(Dmb-off, protonated form), or His on conformation. See appendix E2 for permission obtained 
for reprint. 
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1.6.2 Proposed reaction mechanisms for cobalamine dependent dehalogenases 
For the cobalamin dependent dehalogenases, it has been assumed that the corrinoid is the 
site of reductive dehalogenation (Krone et al., 1989). The first proposed mechanistic model 
predicts that a reduction reaction of the organohalides takes place through a Co(I) free radical 
and no organocobalamin intermediate is formed. An alternate model predicts that an 
organocobalamin product is formed at the first step, and the halogen atom is eliminated in the 
subsequent step in which an aryl-Cobal (III) intermediate is formed (Banerjee and Ragsdale, 
2003). As described in detail in Section 1.7, the recently determined crystal structures of the 
PceA reductive dehalogenase from Dehalospirillium multivorans (Bommer et al., 2014) and 
NpRdhA protein from Nitratireductor pacificus pht -3B (Payne et al., 2015) has provided further 
insights into the free radical reaction pathway of the dehalogenase enzymes. 
 
1.7 Structures and mechanistic insights into dechlorination pathways of functionally 
characterized enzymes 
The first report of an X-ray crystal structure of a functional reductive dehalogenase 
enzyme was that of the tetrachloroethene reductive dehalogenase PceA from Dehalospirillium 
multivorans (Bommer et al., 2014). The crystal structure of this enzyme in the empty state and 
when bound to substrate provides insights into the cobalamine supported dehaloelimination 
reactions catalyzed by this family of enzymes.  
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Figure 1.2 Crystal structure of the dimeric PceA reductive dehalogenase enzyme from 
Dehalospirillium multivorans (Bommer M, Kunze C, Fesseler J, Schubert T, Diekert G and 
Dobbek H (2014) Structural basis of organohalide respiration. Science 6208: 455-8. Reprinted 
with permission from AAAS). One protomer is shown in grey while the other protomer is 
colored. The cofactor binding regions are shown in green color whereas the variable regions are 
in blue. The two [4Fe-4S] are shown as spheres and the corrinoid norpseudo vitamin B12 as 
purple coloured sticks. 
The structure shows that the enzyme exists in the form of the dimer, and each protomer 
consists of two [4Fe-4S] clusters, a norpseudo vitamin B12 binding core and insertion units along 
with N-terminal and C terminal regions (Fig 1.2). The corrinoid norspeudo vitamin B12 has been 
characterized as the cofactor for this enzyme in the Dehalospirillium multivorans species 
(Krautler et al., 2003). The proximal and distal [4Fe-4S] clusters to the cobalt atom of the corrin 
ring are located at the enzyme surface whereas the cofactor binding site is located deep in the 
enzyme structure (Bommer et al., 2014). It can be assumed that swift electron transfer takes 
place inside the protein monomer as the two [4Fe-4S] clusters are located close to the cobalt 
atom of the corrin ring (Fig 1.2). The cofactor binding to the cofactor binding domain of the 
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enzyme is stabilized by hydrogen bonds between the norpseudovitamin B12 ring system and the 
protein matrix (Bommer et al., 2014). It can also be seen that there is one active site in each 
monomer, resulting in two active sites per dimer of the characterized enzyme. 
 
Figure 1.3 Crystal structure of the active site of the PceA reductive dehalogenase enzyme from 
Dehalospirillium multivorans (Bommer M, Kunze C, Fesseler J, Schubert T, Diekert G and 
Dobbek H (2014) Structural basis of organohalide respiration. Science 6208: 455-8. Reprinted 
with permission from AAAS). The arrow shows the substrate entry channel into the active site of 
the protein. White and Blue sticks indicate the location of the polar amino acids and hydrophobic 
amino acids at the active site pocket. 
For the chloroethene substrates to reach the active site of the protein they have to pass 
through a selection filter created by the residues from the N-terminal end of the protein (Bommer 
et al., 2014) and then though a 12 Å hydrophobic channel leading to the active site (Fig 1.3). The 
active site pocket of the PceA protein is bordered by Tyr246, Arg305 and Asn272 out of which 
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the Tyrosine residue has been found to be conserved among reductive dehalogenases and is 
positioned such that its side chains point to the active site of the enzyme (Fig 1.3 and Bommer et 
al., 2014). In addition to the substrate filter, the side chains of the amino acids lining the active 
site also function as a selection filter for substrate binding at the active site. The rigid 
conformations of the side chains allow binding of only specific substrates and hence permits 
binding of substrates that are only compatible in structure at the substrate binding site (Bommer 
et al., 2014).  
The organohalide respiration mechanism involves the transfer of two electrons to the 
halogenated carbon substrate and transfer of a proton to the leaving chloride ion (Bommer et al., 
2014). The first step in the mechanism of reductive dehalogenase catalysis in the PceA enzyme is 
likely to be the reduction of the neutral cobalt(II) in the PceA to the reactive cobalt(I) at the 
active site by weak ligand binding (Bommer et al., 2014). Hence the first electron transfer is 
possibly from the supernucleophile cobalt (I) to perchloroethene resulting in the formation of the 
trichlorovinyl radical (Shey et al., 2000). This PceA enzyme structure model proposes that the 
second electron transfer takes place from the [4Fe-4S] cluster. Transfer of a proton from the 
conserved tyrosine residue at the active site of the enzyme to stabilize the leaving chloride ion is 
perhaps the final step (Glod et al., 1997). Positively charged Arg305 at the active site pocket 
conceivably balances the proton removal from the tyrosine residue. 
The second structure of a functional reductive dehalogenase that was reported was the 
crystal structure of the NpRdhA protein from Nitratireductor pacificus pht -3B (Payne et al., 
2015).  
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Figure 1.4 Crystal structure of the dimeric NpRdhA reductive dehalogenase enzyme NpRdhA 
protein from Nitratireductor pacificus pht -3B (Payne et al., 2015). The monomer is shown in 
two orientations The N-terminal domain is shown in grey. The B12 binding region is shown in 
blue. The Fe-S binding regions are shown as spheres and the flavin reductase type domains in 
green. Reprinted by permission from Macmillan Publishers Ltd: [Nature Publishing Group] 
(Payne KA, Quezada CP, Fisher K, Dunstan MS, Collins FA, Sjuts H, Levy C, Hay S, Rigby 
SEJ & Leys D (2015) Reductive dehalogenase structure suggests a mechanism for B12-
dependent dehalogenation. Nature 7535:513-516), copyright (2015). See appendix E2 for license 
terms from Nature Publishing Group. 
 
The crystal structure of NpRdhA shows that the protein exists as a globular monomer 
comprising a central core domain for cobalamin binding along with N-terminal and C-terminal 
domains (Fig 1.4). The crystal structure also displays the existence of a flavin-reductase domain 
that aids in binding of the cobalamin cofactor in a base off form (Payne et al., 2015 and Fig 1.4). 
Similarity to the structure of the PceA protein exists in the fact that at the C-terminus of the 
protein, both the [Fe-S] binding clusters are located at the surface of the protein and [Fe-S] 
binding clusters are 9.8Å apart (Payne et al., 2015). The active site pocket of the NpRdhA 
protein has been recognized as the empty space above the cobalamin plane (Fig 1.5 Right). 
Docking of the protein with the substrate 3, 5-dibromo-4-hydroxybenzoic acid showed that the 
halogen, bromine atom lies in the active site of the enzyme and in close association with the 
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residues Tyr 426, Lys 488 and Arg 552 (Fig 1.5 Right). The docking also suggested that 3, 5-
dibromo-4-hydroxybenzoic acid is bound to the active site in a deprotonated state as the 
hydroxyl groups of the substrate are hydrogen bonded to Ser 422, Lys 488 and Arg 552 at the 
active site pocket. The enzyme-substrate binding docking was further reinforced by the electron 
paramagnetic resonance spectroscopic study that showed an interaction between the halogen and 
cobalamin (Payne et al., 2015). 
 
 
Figure 1.5 Structure of the NpRdhA protein binding to the corrin ring through 11 hydrogen 
bonds (figure on the left) (Payne et al., 2015). The figure on the right shows the docking of the 
substrate 3,5-dibromohydroxybenzoic acid at the active site of the enzyme complex. The region 
shows the active site cavity of the NpRdhA protein that binds to the substrate halogen atoms 
(Payne et al., 2015). Reprinted by permission from Macmillan Publishers Ltd: [Nature] (Payne 
KA, Quezada CP, Fisher K, Dunstan MS, Collins FA, Sjuts H, Levy C, Hay S, Rigby SEJ & 
Leys D (2015) Reductive dehalogenase structure suggests a mechanism for B12-dependent 
dehalogenation. Nature 7535:513-516), copyright (2015). See appendix E2 for license terms 
from Nature Publishing Group. 
Two potential catalytic mechanisms have been proposed for the enzyme (Payne et al., 
2015). One possible catalytic mechanism for this structure is breakage of the halogen carbon 
bond homolytically after transfer of an electron from the [4F-4S] cluster or the Cob(I)alamin 
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forming the halogen-cob(II)alamin complex (Fig 1.6 Right). The conserved tyrosine 426 residue 
acts as the hydrogen donor to the substrate. A second possible mechanism for the dehalogenase 
catalytic reaction in this enzyme is the breakage of the halogen carbon bond heterolytically (Fig 
1.6 Left). 
 
Figure 1.6 The two proposed dehalogenation mechanisms of catalysis by NpRdhA. The figure on 
the left shows the heterolytic breakage of the carbon-halogen bond and releasing the halogen-
Cob(III)alamin complex. The figure on the right shows the homolytic breakage of the carbon-
halogen bond after reuction by [4Fe-4S] cluster and releasing the halogen Cob (II) alamin 
complex. The conserved tyrosine residue at the active site functions as the hydrogen donor. 
Reprinted by permission from Macmillan Publishers Ltd: [Nature] (Payne KA, Quezada CP, 
Fisher K, Dunstan MS, Collins FA, Sjuts H, Levy C, Hay S, Rigby SEJ & Leys D (2015) 
Reductive dehalogenase structure suggests a mechanism for B12-dependent dehalogenation. 
Nature 7535:513-516), copyright (2015). See appendix E2 for license terms from Nature 
Publishing Group. 
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1.8 Development of primers for amplification of reductive dehalogenases and study of 
dehalogenase gene expression. 
Degenerate and specific primers were developed by Regeard et al. (2003) for the 
detection of chloroethene reductive dehalogenase. For the design of the degenerate primers, three 
chloroethene reductive dehalogenase and three chlorophenol reductive dehalogenase sequences 
that were available at EMBL under accession numbers AF228507 (tceA-De), AF022812 (pceA-
Sm), AJ439607 (pceA-Dr), AF115542 (cprA-Dd),AY013365 (cprA-Dh), AF204275 (cprA-Dc) 
were aligned using several bioinformatic tools. The bioinformatic tools that were used for the 
alignment include T-Coffee (Notredame et al., 2000), Block Maker program (Henikoff et al., 
1995), Motif algorithm (Smith et al., 1990) and the Gibbs Sampler Algorithm (Lawrence et al., 
1993). With the help of these four Bioinformatics tools, seven conserved regions were identified 
and Consensus Degenerate Hybrid Ologonucleotide Primer design method (Rose et al., 1998) 
was used for the development of the degenerate primer sets. The degenerate primers were 
applied to the genomic DNA of Sulfospirilium Multivorens strain K, Dehalobacter restrictus 
strain PER-K23 and Desulfitobacterium sp. strain PCE1. Clones obtained using the degenerate 
primers were analyzed, and three novel putative rdh genes were detected in addition to the 
previously known chloroethene reductive dehalogenase genes. Specific primers for pceA gene 
was developed by using the Primer3 software (Rozen and Skaletsky 2000). The low copy 
number of the target genes was a drawback, and so a nested PCR method was developed in 
which amplification was carried out first by degenerate primers followed by specific primers to 
detect the low copy number genes. 
The degenerate primers designed by Holliger et al. (2003) were further used by Marzorati 
et al. (2007) to amplify potential dehalogenating genes in a mixed culture that was 
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dechlorinating 1,2-dichloroethane to ethene. The PCR amplicons were further cloned and were 
used to develop specific primers for inverse and direct PCR. The inverse and the direct PCR 
approach using the specific primers designed produced a 7.4 Kb novel dehalogenating gene 
cluster. This gene cluster was found to have five open reading frames namely dcaA, dcaB, dcaC, 
dcaT, and orf1. The amino acid sequences of the dehalogenating cluster were aligned with other 
known dehalogenating enzyme sequences and it was found to be similar to the aligned 
sequences; it was concluded that the novel gene cluster encoded protein specific for 1,2-DCA 
dechlorination. 
Krajmalnik-Brown et al. (2004) developed degenerate primers for amplification of a gene 
encoding a vinyl chloride reductase from mixed and pure cultures of Dehaloccoides mccartyi 
using the Clustal W software. The twin arginine motif (Tat signal sequence) and a conserved 
region internal to Dehalococcoides rdhB genes were identified and used for the development of 
degenerate primer sets RRF2 and BIR. This primer set when applied on the cDNA of mixed and 
pure cultures of Dehaloccoides mccartyi strain BAV1 gave an amplicon of the correct expected 
size of 1700 bp showing that both the rdhA and rdhB genes were transcribed together. A clone 
library was extablished using the PCR product and this lead to the identification 7 new putative 
reductive dehalogenases in strain BAV1 in pure and mixed cultures.  
The degenerate primer set RRF2 and BIR was again used by Waller et al. (2005) to 
amplify and study the differential expression of reductive dehalogenase genes in Dehaloccoides 
containing mixed culture KB1. The degenerate primer sets were used for the amplification of 
both genomic DNA and also cDNA for the transcriptional analysis. These genes were also 
amplified in the transcriptional study, and these genes have shown remarkable similarities with 
the protein sequences of previously known reductive dehalogenases. In the transcriptional study 
 18 
 
of the mixed KB1 cultures it was shown that multiple reductive dehalogenase were transcribed at 
the same time during the dechlorination of a single compound. Upregulation of as many as 29 
rdhA genes were observed during the dechlorination of 1,2,3-trichlorobenzene and 1,2,4-
trichlorobenzene in pure cultures of Dehalococcoides mccartyi strain CBDB1. Degenerate 
primers were designed for amplification of all 32 rdhA genes from the genome of 
Dehalococcoides mccartyi strain CBDB1. RT-PCR using these primers along with tRFLP 
showed the upregulation of multiple rdhA genes (Wagner et al., 2009). Evidence of upregulation 
of multiple genes encoding reductive dehalogenase proteins has also been observed in 
Dehalococcoides mccartyi strain 195 during the dechlorination of tetrachloroethene, 
trichloroethene, and 2,3-dichlorophenol (Fung et al., 2007). This study showed the highest 
transcript levels for the genes encoding PceA and TceA among all the transcripts deteced. The 
high translational levels of PceA and TceA proteins were also detected by proteomic analysis. 
1.9 Regulatory genes associated with dehalogenase genes 
The majority of the rdhA genes in Dehalococcoides mccartyi are associated with either 
two component system (TCS) regulators or MarR regulators (Kube et al., 2005; Seshadri et al., 
2005). The two component systems (TCS) regulators consist of a histidine kinase and a response 
regulator. The histidine kinase contains transmembrane domains and is responsible for transfer 
of signals to the response regulator through a complex autophosphorylation pathway (Galperin, 
2006). MarR proteins, on the other hand, often function as repressor proteins and regulate gene 
expression in response to change in environment, availability of antibiotics, and in response to 
aromatic compound metabolism (Wilkinson et al., 2006). MarR proteins have a helix-turn-helix 
DNA recognition fold, and in the presence of an aromatic ligand, they are typically released from 
the promoter sequences thereby inducing gene expression (Wilkinson et al., 2006).  
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Table 1.1 Number of rdh genes and associated regulated genes from Dehalococcoides mccartyi 
genomes (Wagner et al., 2013). 
 
  Genes encoding TCS systems 
regulators 
Genes encoding MarR regulators 
strain rdhAB genes total Adjacent to rdhA 
genes 
total Adjacent to rdhA 
genes 
CBDB1 32 24 14 16 10 
195 17 19 10 8 3 
BAV1 11 13 5 4 1 
GT 20 3 1 12 7 
VS 36 21 11 14 10 
 
It is assumed that both TCS systems regulators and MarR regulators act as regulatory 
genes for the reductive dehalogenases. It has been proposed in Dehalococcoides mccartyi strain 
CBDB1 that the MarR protein (encoded by the gene locus CbdbA 1625) acts as a repressor. 
Promoter probe assays have demonstrated that the MarR protein plays a role in regulation of the 
rdhA genes (Wagner et al., 2013). 
1.10 Previous studies of heterologous expression of reductive dehalogenases 
The first attempts to heterologously express a functional reductive dehalogenase was 
reported by Neumann et al. (1998). The tetrachloroethene reductive dehalogenase pceA from 
Dehalospirillum multivorans was expressed nonfunctionally and in the insoluble fraction in E. 
coli and only in the presence of rare E. coli tRNA4
ARG
. The presence of the E. coli tRNA4
ARG
 
compensated for the difference in codon usage in D. multivorans and E. coli. The reason for the 
production of a non-catalytically-active enzyme was attributed to the fact that the recombinant 
protein expressed in E. coli was an unprocessed PCE dehalogenase. The other reason presumed 
for the production of inactive protein was that the Fe/S clusters and the corrinoid cofactors were 
not incorporated in the protein since E. coli is not able to synthesize corrinoids. 
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The pceA gene from Desulfitobacterium sp. strain Y51 was also expressed in a non-
catlytically-active form in E. coli (Suyama et al., 2002). Isopropyl β-D-1-thiogalactopyranoside 
induced cell extracts of recombinant E. coli cells harbouring the pceA in a pET expression 
system gene failed to show dehalogenase activity under both aerobic and anaerobic conditions. 
Attempts to refold the protein from the insoluble fraction did not result in the production of a 
functionally active protein, and again it was assumed that the absence of a de novo cobamide 
biosynthesis pathway in E. coli led to the production of a non-functional enzyme. 
The first instance of heterologous production of a soluble reductive dehalogenase was the 
pceA gene from Dehalobacter restrictus (Sjuts et al., 2012). The soluble protein was expressed 
in an E. coli host system by fusing the PceA with a strep tag as a solubility tag (Trigger factor) 
and by expressing the protein at cold temperatures. The fusion protein was purified using a 
StrepTactin Sepharose resin and the 4Fe-4S clusters were incorporated into the protein by 
incubation with NaS and FeCl3 under anaerobic conditions. The protein, however, was still 
enzymatically inactive, and again it was assumed that the right cobamide was not available for 
the enzyme to be functional or the 4Fe-4S was not completely reconstituted to produce the 
functional enzyme. 
The first report in the literature of successful heterologous expression of a catalytically 
active reductive dehalogenase came out very recently in (Mac Nelly et al., 2014), and for the 
first time, a genetic system for the production of a functional reductive dehalogenase was 
identified. Shimwellia blattae (ATCC 33430) was used as the host for the expression of 
functional reductive dehalogenase because of its ability to synthesize cobamides de novo and 
hence was preferred in place of the standard host E. coli. The tetrachloethene reductive 
dehalogenase (PceA) of the Desulfitobacterium hafniense strain Y51 was functionally expressed 
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in the S. blattae cells. S. blattae cells were grown under anoxic conditions for the production of 
the recombinant protein, and glycerol was used as the sole energy source. It was observed that 
the production of the soluble enzyme increased when the trigger factor chaperone PceT located 
downstream was co expressed along with the pceA gene. After the PceA reductive dehalogenase 
was functionally expressed, additional experiments were performed using the rdhA3 of D. 
hafniense DCB-2, and catalytically active RdhA3 was again expressed. The catalytic activity of 
the PceA enzyme was notably increased when 5,6-dimethylbenzimidazole (DMB) and 
hydroxocobalamine were added to the growth medium of the recombinant enzyme-producing 
cells, suggesting their roles as cofactors for the processing of the enzyme. Also, it was reported 
that active form of the enzyme was also expressed in the absence of the trigger factor (PceT); 
hence, this system could possibly be used for the functional expression of other dehalogenase 
genes with unknown substrate specificity existing in the present databases. 
 
 
Figure 1.7 Heterologous production of soluble functional PceA from S. blattae (McNelly et al., 
2014, reprinted with permission from ASM). Strep tagged soluble PceA detected by 
immunoblot. Solubility of the PceA protein was found to be more when the PceT protein was co 
expressed.  
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1.11 Research Objectives 
 
The first objective of research described in this dissertation was to gain insights into the 
extent of reductive dehalogenase gene expression in Dehalogenimonas lykanthroporepellens BL-
DC-9
T
 during dechlorination of 1,2-dichloroethane (1,2-DCA), 1,2-dichloropropane (1,2-DCP), 
and 1,2,3-trichloropropane (1,2,3-TCP). The second research objective was to develop a method 
for functional heterologous expression of an active dehalogenase enzyme using a suitable host.  
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Chapter 2. Expression of putative reductive dehalogenase genes from BL-DC-9
T
 during 
dechlorination Of 1,2-DCA, 1,2-DCP and 1,2,3-TCP
1
 
 
2.1 Introduction 
 
As described in Chapter 1, the genome of D. lykanthroporepellens strain BL-DC-9
T
 
(GenBank accession no. CP002084) contains 25 loci having reductive dehalogenase homologous 
(rdh) genes scattered throughout the chromosome (Siddaramappa et al., 2012) (Table 2.1). For 
genera other than Dehalogenimonas (for which only one functional enzyme has yet been 
characterized) (Padilla-Crespo et al., 2014), the genes encoding enzymes characterized to date 
that are involved in catalyzing the anaerobic reductive dehalogenation of chlorinated solvents are 
organized in rdhAB operons encoding two components: a 50-65 kDa protein (RdhA) that 
functions as a reductive dehalogenase and a ~10 kDa hydrophobic protein with transmembrane 
helices (RdhB) that is thought to anchor the RdhA to the cytoplasmic membrane (Magnuson et 
al., 2000; Maillard et al., 2003; Smidt et al., 2004; Futagami et al., 2008). Genera sharing this 
feature include Sulfurospirillum, Dehalobacter, Desulfitobacterium, and Dehalococcoides 
(Miller et al., 1998; Neumann et al., 1998; Magnuson et al., 2000; Maillard et al., 2003; Suyama 
et al., 2002; Müller et al., 2004; Krajmalnik-Brown et al., 2004; He et al., 2005; Padilla-Crespo 
et al., 2014). Previously characterized RdhA proteins also contain a twin-arginine motif near the 
N-terminus that is thought to be associated with the twin-arginine translocation (TAT) system, a 
specialized system involved in the secretion of folded proteins across the bacterial inner 
membrane into the periplasmic space (Stanley et al., 2000). Two conserved motifs each 
                                                 
1
 Portions of this chapter previously appeared as [Kalpataru Mukherjee1 , Kimberly S. Bowman1,2, Fred A. 
Rainey1,3, Shivakumara Siddaramappa4,5, Jean F. Challacombe4 & William M. Moe2 Dehalogenimonas 
lykanthroporepellens BL-DC-9T simultaneously transcribes many rdhA genes during organohalide respiration with 
1,2-DCA, 1,2-DCP, and 1,2,3-TCP as electron acceptors FEMS Microbiol Lett. 2014 May;354(2):111-8. 
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containing four cysteine residues, a feature associated with binding iron-sulfur clusters (Bruschi 
& Guerlesquin, 2000) have also been reported to occur near the C-terminus of previously 
characterized rdhA proteins (Magnuson et al., 2000, Maillard et al., 2003; Hug et al., 2013). 
All of the rdhB code for proteins predicted to contain two or three transmembrane helices 
(Table 2.2), consistent with observations for putative dehalogenase membrane-anchoring 
proteins in Dehalococcoides mccartyi strains (Kube et al., 2005; Seshadri et al., 2005; 
McMurdie et al., 2009; Padilla-Crespo et al., 2014). 
The majority of rdh genes in Dehalococcoides strains are associated with MarR or two 
component system transcriptional regulators. For example, Dehalococcoides mccartyi strain 195 
has transcriptional regulators for 17 of the rdh genes present in its genome while 
Dehalococcoides strain CBDB1 has transcriptional regulators for all 32 of its rdh genes (Kube et 
al., 2005; Seshadri et al., 2005). In contrast, in the genome sequence of Dehalogenimonas 
lykanthroporepellens BL-DC-9
T
, such transcriptional regulators are associated with only four of 
the 25 rdhA genes. These include one MarR type transcriptional regulator and three two-
component system transcriptional regulators (Table 2.3).  
The broad goal of experiments presented in this chapter was to determine which of the 
rdh genes are expressed by D. lykanthroporepellens strain BL-DC-9
T
 during the anaerobic 
reductive dechlorination of different compounds and investigate genes that may regulate their 
expression. Oligonucleotide primers were designed and PCR protocols that allow PCR 
amplification of all 25 rdhA genes (Table 2.4) and transcription factors (Table 2.5) were 
developed. Subsequently, the PCR primers and protocols were employed in conjunction with 
reverse transcriptase PCR (RT-PCR) to determine which genes were expressed during growth of 
BL-DC-9
T
 with the chlorinated solvents 1,2-DCA, 1,2-DCP, and 1,2,3-TCP.  
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Table 2.1: Characteristics of putative reductive dehalogenases (rdhA) of D. lykanthroporepellens BL-DC-9
T
Locus tag, protein Chromosomal 
location 
ORF 
Size 
(bp) 
GC % IS element 
association 
Tat 
signal 
sequence 
Fe-S binding 
motif 
#1 
Fe-S binding 
motif 
#2 
Closest homolog 
Locus, protein, identity
a
Cognate 
rdhB 
Start 
(bp) 
Stop 
(bp) 
Dehly_0068, 460 aa 65748 64366 1383 57.27 None + CX2CX2CX3C CX9CX4CX3C dcmb_1434, 482aa, 40% None 
Dehly_0069, 454 aa
b 
67393 66029 1365 60.66 Dehly_0070 - CX2CX2CX3C CX9CX4CX3C cbdbA1491, 482 aa, 36% None 
Dehly_0075, 300 aa
b
 75099 74197 903 55.92 Dehly_0076 - CX2CX2CX3C CX9CX4CX3C cbdbA1542, 487 aa,39% None 
Dehly_0121, 469 aa 115115 116524 1410 51.21 None + CX2CX2CX3C CX8CX2CX3C DehaBAV1_0281, 470 aa, 39% None 
Dehly_0156, 467 aa 153539 154942 1404 59.19 None + CX2CX2CX3C CX2CX2CX3C DhcVS_1340, 480aa,43% Dehly_0157 
Dehly_0274, 472 aa 262130 263548 1419 45.38 None + CX2CX2CX3C CX8CX2CX3C DehaBAV1_0281, 470aa, 45% None 
Dehly_0275, 493 aa 263669 265150 1482 45.34 None + CX2CX2CX3C CX2CX2CX3C DehaBAV1_0284, 496 aa, 78% Dehly_0276 
Dehly_0283, 476 aa 269792 268362 1431 43.89 Dehly_0284 + CX2CX2CX3C CX14CX2CX3C cbdbA84, 488 aa, 38% None 
Dehly_0479, 339 aa
b
 447957 448976 1020 49.71 Dehly_0480 + None None cbdbA1563, 465 aa,40% None 
Dehly_0849, 475 aa 830820 832247 1428 54.62 None + CX2CX2CX3C CX9CX4CX3C cbdbA1542, 487 aa,38% None 
Dehly_0910, 464 aa 896375 894981 1395 53.62 None + CX2CX2CX3C CX8CX2CX3C DhcVS_1342, 473 aa, 59% None 
Dehly_1054, 473 aa 1050007 1048586 1422 54.50 None + CX2CX2CX3C CX2CX2CX3C DhcVS_1340, 480 aa,44% Dehly_1053 
Dehly_1148, 462 aa 1129672 1128284 1389 51.33 None + CX2CX2CX3C CX11CX2CX3C GY50_1378, 508aa, 36% None 
Dehly_1152, 458 aa 1133813 1132437 1377 56.21 None + CX2CX2CX3C CX2CX2CX3C DehaBAV1_0284, 496 aa, 45% Dehly_1151 
Dehly_1328, 476 aa 1305989 1307419 1431 47.87 None + CX2CX2CX3C CX10CX2CX3C cbdbA1563, 465aa, 43% None 
Dehly_1355, 474 aa 1329395 1330819 1425 47.09 Dehly_1354 + CX2CX2CX3C CX11CX2CX3C cbdbA1542, 487 aa, 41% None 
Dehly_1514, 455 aa 1485472 1484105 1368 44.37 Dehly_1515 + CX2CX2CX3C CX16CX2CX3C cbdbA1563, 465 aa, 35% None 
Dehly_1520, 129 aa 1493625 1494014 390 37.44 Dehly_1521 - None None DehaBAV1_0281, 470 aa, 32% None 
Dehly_1523, 340 aa 1495262 1496284 1023 43.01 Dehly_1522 - CX2CX2CX3C CX19CX2CX3C DhcVS_1353, 514 aa, 31% None 
Dehly_1524, 482 aa 1496492 1497940 1449 44.93 Dehly_1526 + CX2CX2CX3C CX21CX2CX3C AGS15112, 484 aa, 92% Dehly_1525 
Dehly_1530, 473 aa 1503758 1502337 1422 49.23 Dehly_1529 + CX2CX2CX3C CX11CX7CX3C dcmb_1434, 482 aa, 39% None 
Dehly_1534, 295 aa
b
 1507895 1507008 888 54.17 Dehly_1535 - CX2CX2CX3C CX2CX2CX3C DehaBAV1_0284, 496 aa, 49% Dehly_1533 
Dehly_1540, 465 aa 1514181 1515578 1398 47.57 Dehly_1542 + CX2CX2CX3C CX2CX2CX3C DehaBAV1_0281, 470 aa, 35% None 
Dehly_1541, 51aa
c
 1515618 1515773 156 59.62 None - None None DhcVS_1421, 475 aa, 55% None 
Dehly_1582, 452 aa 1547392 1546034 1359 60.56 Dehly_1583 - CX2CX2CX3C CX8CX2CX3C DehaBAV1_0281, 470 aa, 42% None 
a
Identity across the entire length of the query protein 
b
Annotated as pseudogenes  
c
Truncated ORF ,annotated as hypothetical proteins 
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Table 2.2. Characteristics of putative reductive dehalogenase membrane anchoring proteins 
(rdhB) of D. lykanthroporepellens BL-DC-9
T
.
Locus Tag, 
Protein 
Chromosomal 
Location 
ORF 
size (bp) 
GC % TM
a
 Cognate 
rdhA 
Closest homolog 
Locus tag, protein, identity 
Start Stop 
Dehly_0157, 93 aa 154978 155259 282 61.35 3 Dehly_0156 GY50_1404, 95 aa, 43% 
Dehly_0276, 91 aa 265171 265446 276 40.58 3 Dehly_0275 DehaBAV1_0283, 88 aa,72% 
Dehly_1053, 94 aa 1048546 1048262 285 57.19 3 Dehly_1054 DhcVS_1363, 95 aa, 41% 
Dehly_1151, 90 aa 1132415 1132143 273 51.28 3 Dehly_1152 DhcVS_1307, 89 aa, 43% 
Dehly_1504, 88 aa 1476013 1476279 267 57.30 3 None dcmb_118, 90 aa, 63% 
Dehly_1525, 72 aa 1497959 1498177 219 35.16 2 Dehly_1524 DET0163, 76 aa, 47% 
Dehly_1533, 88 aa 1506976 1506710 267 48.69 3 Dehly_1534 btf_1459, 89 aa,51% 
a 
Number of transmembrane helices as predicted by TMHMM2.0 (Krogh et al., 2001) 
Table 2.3: Characteristics of putative transcriptional regulators associated with rdhA genes. 
Locus Tag 
Protein 
Type of regulatory element Associated rdhA 
Dehly_0120 MarR Dehly_0121 
Dehly_0270 Two component system transcriptional 
regulator 
Dehly_0274 
Dehly_1149 Two component system transcriptional 
regulator 
Dehly_1148, 
Dehly_1152 
Dehly_1531 Two component system transcriptional 
regulator 
Dehly_1530 
2.2 Materials and Methods 
2.2.1 Primer design and PCR protocols 
Oligonucleotide primers specific for the rdhA and rdhB genes of D. lykanthroporepellens 
BL-DC-9
T
 were designed using a combination of the Primer3 software package (Rozen &
Skaletsky, 2000)/ Blast at NCBI/Primer-Blast and also by manual selection after alignment of all 
rdh genes in the genome using the BioEdit 7.05.3 software package (Hall, 1999). The Primer 3 
software enabled the screening of hairpin loops and primer dimers during primer design. Also 
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the primer specificity was checked using Blast. For the six rdhA genes with cognate rdhB genes, 
primers were selected to span the two genes (i.e., forward primer targeting location in rdhA and 
reverse primer binding site in rdhB). Primers were likewise designed for the amplification of all 
four regulatory genes. 
Table 2.4. Primers and annealing temperatures used for the detection of rdh gene expression. 
Target locus 
tag 
Target 
Gene ID 
Primer ID Primer sequence(5’-3’) 
Expected 
product size 
(bp) 
Annealing 
temp (°C) 
Dehly_0068 9389745 
Dehly_0068F TCATGAAAGTCCTCGGCCTG 
434 55 
Dehly_0068R CTCTTCCTTGGTACCTTCCC 
Dehly_0069 9389746 
Dehly_0069R TAGCCGAGGGTGCGGACGAA 
360 60 
Dehly_0069F TATCCCCCGCTGGAACGGCA 
Dehly_0075 75099??? 
Dehly_0075R GCGTAGTAGCCGAGGGAAGT 
270 58 
Dehly_0075F CCATGAGGACACCACCGTGAAG 
Dehly_0121 9389797 
Dehly_0121F GACCGGCGCAGACAGTTGCT 
462 60 
Dehly_0121R GACGGCATCATACCGCCCGG 
Dehly_0156-
Dehly_0157 
9389835, 
9389836 
Dehly_0156F ACTGTGCCGGTTGTCAGGCG 
503 65 
Dehly_0157R AGCCGAAGAGGCCCAGCAGA 
Dehly_0274 9389954 
Dehly_0274F GGCCGAACGCTCCATGGGAT 
345 63 
Dehly_0274R CCATGCCGAAACCACCCGGA 
Dehly_0275-
Dehly_0276 
9389955, 
9389956 
Dehly_0275F TCCACATTGCCCGGTTTGCCA 
419 60 
Dehly_0275R AGTCCCGCCGTTGGCTCATA 
Dehly_0283 9389963 
Dehly_0283R GTCGCACTCCACCTTGGTAA 
438 60 
Dehly_0283F ACTTGGATTGTCTGGGGCAG 
Dehly_0479 447957 
Dehly_0479F TCGCCCAAGGGGGACTGGAA 
410 55 
Dehly_0479R ACGCCTACGTCCCTGGCTCC 
Dehly_0849 9390556 
Dehly_0849F ATACCAGGCGGTCGGCCAGT 
372 60 
Dehly_0849R CCTGAGGTGCAGGCGTTGGG 
Dehly_0910 9390618 
Dehly_0910R CGGCATCAAGCACTGGCCCA 
244 63 
Dehly_0910F ATCCCGGTTCCACCAGGCCA 
Dehly_1053-
Dehly_1054 
9390762, 
9390763 
Dehly_1053F ACGACCCCACCTGGGACACC 
608 67 
Dehly_1053R CCAACCGGAAACGGCCAGCA 
Dehly_1148 9390857 
Dehly_1148F GGCACTTTGGCGGGTCGGAA 
551 60 
Dehly_1148R GGCGTCCTCGGTGCTGATCG 
Dehly_1151-
Dehly_1152 
9390860, 
9390861 
Dehly_1152F TTGCCCGCATTGTCCGCAGT 
349 65 
Dehly_1152R GGCGCCCATCAGCCATTCGT 
Dehly_1328 9391042 
Dehly_1328F CCAACCACCGAAGTTGACTGG 
347 60 
Dehly_1328R GCCCCATAAAAGCGTGCGGC 
Dehly_1355 9391069 
Dehly_1355F GGGATGGCAGTCAACCCGGC 
464 60 
Dehly_1355R AACGCCGCCCGAATCATCCG 
Dehly_1514 9391237 
Dehly_1514F AGCCGGACTAGGTGCAGCCT 
310 58 
Dehly_1514R TGCGGTACGGCCGCCAAATT 
Dehly_1520 9391243 
Dehly_1520F TGGACCAGATGTTGAGTGCATCGG 
217 68 
Dehly_1520R TGCAGAATGCCATTTGTTTCGCGG 
Dehly_1523 9391246 
Dehly_1523F TGCCACGCTGGGAAGGCAAG 
892 68 
Dehly_152 R TCCGGCAGGTCGATGTCCCA 
Dehly_1524-
Dehly_1525 
9391247, 
9391248 
Dehly_1524F TGGCACCAGTACCTGCCCGCTAT 
168 58 
Dehly_1524R GACAACGCCAGGCTGAGATTCTGC 
Dehly_1530 9391253 
Dehly_1530F AGTTGCCCAAGCGGCAAGGG 
196 60 
Dehly_1530R ATCCACCGCTTCTGCGCCAC 
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Target locus 
tag 
Target 
Gene ID 
Primer ID Primer sequence(5’-3’) Expected 
product size 
(bp) 
Annealing 
temp (°C) 
Dehly_1533-
Dehly_1534 
9391256, 
9391257 
Dehly_1533F ATGGGGTGTTACCCCGCGT 
677 65 
Dehly_1533R GCCGATGGTGGCGGCTGTTT 
Dehly_1540 9391263 
Dehly_1540F TTGTGGGCGCTGGTAACGCT 
387 50 
Dehly_1540R CCACGCGGACGATAGTGCCG 
Dehly_1541 9391264 
Dehly_1541F  TTCATGAAAGGGCTTGGGCTTGCC 
115 50 
Dehly_1541R  TCACACGGTAGTTCGTTTCCGG 
Dehly_1582 9391305 
Dehly_1582F  GGATGACAGCTATCCCGGTG 
437 55 
Dehly_1582R AGTTGACGTACCAGCCCTTG 
Primers were tested using genomic DNA of D. lykanthroporepellens BL-DC-9
T
 (=JCM
15061
T
 = ATCC BAA-1523
T
), extracted using an UltraClean Microbial DNA isolation kit
(MoBio Laboratories, CA), as template in PCR reactions. PCR was carried out in 25 µL reaction 
volumes using 10 ng of genomic DNA (as quantified by NanoDrop 2000 spectrophotometer, 
Thermo Fisher Scientific), 0.4 mM dNTPs, 1 U Platinum Taq polymerase (Invitrogen) and 0.4 
µM of forward and reverse primers. Amplifications were carried out with initial denaturation at 
95°C for 2 min, thirty cycles consisting of 95°C for 15 sec, primer specific annealing 
temperature for 30 sec (Tables 2.4 and 2.5), and extension at 68°C for 60 sec. A final extension 
was carried out at 68°C for five min. 
Table 2.5: Primers and annealing temperature used for study of transcription factor gene 
expression.  
Target locus 
tag 
Primer ID Primer sequence (5’-3’) 
Expected 
product size 
(bp) 
Annealing 
temp (°C) 
Dehly_0120 
Dehly_0120F GTCATGCGGATGTTTCCGTG 
225bp 59 
Dehly_0120R AAGGGGTTTGTCAGCTCTCG 
Dehly_0270 
Dehly_0270F AGCAGTTTCGCCTTCTCCAA 
143bp 59 
Dehly_0270R CGACTACCAGGATGTCAGGC 
Dehly_1149 
Dehly_1149F CCGAGTCCGGAGACGTTATG 
622bp 59 
Dehly_1149R ACGATCCCGGAGTAGTGGAA 
Dehly_1531 
Dehly_1531F AATCCAGCACCTGCTTCTCC 
185bp 59 
Dehly_1531R CAAAAACACACCGCGCAAAC 
(Table 2.4 Continued) 
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Following PCR, amplification products were separated via electrophoresis in a 2% (m/v) 
agarose gel and visualized using ethidium bromide staining. A 100 bp ladder (Sigma-Aldrich) 
was used to estimate the sizes of PCR amplicons. Production of amplicons of the size expected 
based on the genome sequence was taken as an initial indication of success. PCR products were 
subsequently sequenced to verify that the primers and PCR protocols allowed unique detection 
of the intended gene targets. Sequencing was performed using the BigDye Terminator version 
3.1 (Applied Biosystems) in conjunction with an ABI prism 3130 sequencer.  
To evaluate the detection limits for the PCR primers and thermal protocols (Tables 2.4 
and 2.5), genomic DNA from D. lykanthroporepellens BL-DC-9
T
 quantified using a Qubit 
dsDNA HS assay kit (Invitrogen) in conjunction with a Qubit2 fluorometer was serially diluted 
(10 ng/µL to 0.00015 ng/µL) and then used as PCR template (with 1 µL template DNA per 
reaction). This corresponds to 5.8×10
6
 to 8.7×10
1
 genome copies/PCR. PCR conditions and 
amplicon detection were as described above.  
2.2.2 Cell culture  
Cultures for transcription experiments were grown in 25 mL glass serum bottles 
(Wheaton) sealed with butyl rubber stoppers and aluminum crimp caps. Each serum bottle 
contained 15 mL of anaerobic basal liquid medium with titanium citrate as reducing agent 
(Maness et al., 2012) and 10 mL gas headspace comprised of 10% CO2, 80% N2, and 10% H2 
(mol%). Triplicate bottles spiked with filter sterilized 1,2-DCP, 1,2-DCA, or 1,2,3-TCP to reach 
an aqueous phase concentration of 2 mM following dissolution and equilibration were inoculated 
(6% v/v) with D. lykanthroporepellens BL-DC-9
T
. Incubation was in the dark at 30°C without 
mixing. Triplicate bottles prepared, inoculated, and incubated in identical fashion but without 
addition of chlorinated solvents were prepared at the same time as controls. Cultures used for 
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inoculation of bottles used in transcription experiments were grown on the same solvent prior to 
use as inoculum (e.g., the D. lykanthroporepellens BL-DC-9
T
 culture inoculated into bottles 
containing 2 mM 1,2-DCA was grown on 2 mM 1,2-DCA) and were sparged with a gas mixture 
comprised of 10% CO2, 80% N2, and 10% H2 (mol%) to remove residual chlorinated compounds 
prior to use as an inoculum. Dechlorination was monitored by gas chromatography as described 
previously (Yan et al., 2009). Bottles were incubated until 25-65% of the parent chlorinated 
solvent was dechlorinated (see Table 3) prior to harvesting biomass.  
2.2.3 RNA extraction and purification  
Cells for RNA extraction were collected by centrifugation. Serum bottles were opened 
inside an anaerobic chamber (Coy) supplied with gas headspace comprised of 10% CO2, 80% 
N2, and 10% H2 (mol %), and 15 mL culture volumes were transferred into plug sealed 
centrifugation tubes (Corning). The centrifuge tubes were removed from the anaerobic chamber 
and centrifuged at 5900×g for 30 min at 4°C. After briefly opening tubes to decant supernatant 
(< 1 min), the remaining cell pellets were immediately frozen by submerging tubes in liquid N2. 
Frozen cells were resuspended in 1 mL of TRI reagent (Molecular Research Center), and RNA 
was extracted using the modified guanidium thiocyanate-phenol-chloroform RNA extraction 
method of Chomczynski et al. (2006). Extraction was with 200 µL chloroform and precipitation 
was with 500 µL isopropanol. For purification, the RNA pellet was washed with two rounds of 
70% ethanol, and RNA was eluted in 30 µL of nuclease free water. The extracted RNA was 
subjected to two rounds of DNase treatment using an RQ1 RNase-free DNase kit (Promega) 
before aliquots of RNA extract from each sample were analyzed using an RNA 6000 Pico kit 
(Agilent) in conjunction with an Agilent 2100 Bioanalyzer to assess RNA quality, quantify 
concentrations, and calculate the RNA integrity number (RIN, Schroeder et al., 2006). 
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2.2.4 Reverse transcription experiments 
End point RT-PCR was carried out using the rdh-specific primers (Table 2.4) and primers 
targeting the seven regulatory genes (Table 2.5) the same day that RNA was extracted. In the 
RT-PCR reaction, cDNA synthesis and PCR were carried out in the same tube using the 
SuperScript III one step RT-PCR system with Platinum Taq DNA polymerase kit (Invitrogen). 
0.5 µL of DNase-treated RNA extract was used as template for each reaction. The RT-PCR 
thermal program was 55°C for 30 min for reverse transcription followed by initial denaturation at 
95°C for 2 min and then thirty cycles of 95°C for 15 sec, primer specific annealing temperature 
for 30 sec (see Table 2.4 and 2.5) and extension at 68°C for 60 sec. A final extension was carried 
out at 68°C for five min. To check for the presence of genomic DNA contamination and as a 
negative control, in parallel, PCR reactions were carried out with 0.5 µL RNA extract serving as 
template in PCR using Platinum Taq DNA polymerase in the absence of reverse transcriptase 
enzyme. 
The end point RT-PCR products and samples from control PCR reactions were analyzed 
by agarose gel electrophoresis. The detection of amplicons of the correct size based on the 
genome sequence in reverse transcribed but not direct PCR (i.e., lacking reverse transcription) 
was used as an indicator of gene expression. To verify amplicon identity, RT-PCR amplicons 
were excised from the electrophoresis gels, eluted using a MinElute gel extraction kit (Qiagen), 
and sequenced. The RT-PCR reactions were carried out in triplicate for each of the primer sets 
using cells harvested from triplicate bottles. 
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2.3 Results 
2.3.1 Primer design and detection limits 
Using genomic DNA as template, PCR products of the correct size, as predicted from the 
genome sequence, were observed at template DNA concentrations of 0.001 ng/µL and higher 
(Figures 2.1 and 2.2) but not at 0.00075 ng/µL and lower for all of the final PCR primer 
combinations and thermal protocols tested (Tables 2.4 and 2.5). This corresponds to a detection 
limit of 5.8×10
2
 genome copies per PCR reaction. Sequencing of expected sized PCR products 
showed that the amplicons were exact copies of target loci present in the chromosome of D. 
lykanthroporepellens BL-DC-9
T
.  
 
 
 
 
 
Figure 2.1. Agarose gel image showing detection of expected sized amplicons amplified using 
the designed rdh primers using DNA template concentration of 0.001 ng/µL. The molecular 
marker designated as M is DirectLoad 100 bp Low Ladder (Sigma-Aldrich). 
M  0068 0069 0075  0121  0156 0274 0275 0283  0479  0849 0910 1053 1148 1152  M 
M  1328   1355      1514   1520   1523    1525  1530    1534    1540   1541    1582     M 
1000 bp 1000 bp 
1000 bp 1000 bp 
500 bp 
500 bp 
500 bp 
100 bp 100 bp 
100 bp 100 bp 
500 bp 
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2.3.2 Expression of rdhA genes during dechlorination of different substrates 
Reductive dechlorination was observed in the bottles inoculated with strain BL-DC-9
T
 
and spiked with all three of the chlorinated compounds provided as electron acceptors following 
pathways described previously (i.e., 1,2-DCA transformed to ethene, 1,2-DCP transformed to 
propene, and 1,2,3-TCP transformed to allyl chloride, Moe et al., 2009; Yan et al., 2009). The 
amount of dechlorination observed at the time when bottles were sacrificed is provided in Table 
2.6. The extracted RNA was of high quality, with RNA integrity numbers (RIN) ranging from 
7.5-9.6 (Table 2.6). Appendix A shows the results from the Bioanalyzer assay to check the RNA 
quality. 
For BL-DC-9
T
 cells harvested from all replicates of cultures that were actively 
dechlorinating each of the three chlorinated alkanes (1, 2-DCA, 1,2-DCP and 1,2,3-TCP), 
amplicons were detected in RT-PCR with 19 of the 25 rdh-specific primer sets (Table 2.6). No 
amplicons were detected following RT-PCR with RNA extracted from triplicate bottles prepared 
at the same time and incubated under identical conditions but without the presence of a 
halogenated electron acceptor. No PCR amplicons were observed in any of the tests when RNA 
extract was used as template in PCR without reverse transcription (conducted to detect the 
presence of genomic DNA contamination in the RNA extracts). Agarose gel images supporting 
these results are shown in Appendix B. The amplicons detected following the RT-PCR were 
sequenced using the BigDye Terminator version 3.1 (Applied Biosystems) in conjunction with 
an ABI prism 3130 sequencer. The sequences were aligned with the target genes from the 
genome sequence. Sequence alignments using the sequenced RT-PCR result showed that the 
right targets were detected in the RT-PCR experiments targetting the rdh genes. The RT-PCR 
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result for the target Dehly_1541 had two bands. Both the bands were excized from the gel and 
sequenced and the expected sized band was identified as the correct target after sequencing. 
 Of the 17 “full length” rdhA genes, 13 were transcribed during dechlorination of all three 
halogenated solvents (Dehly_0121, Dehly_0156/Dehly_0157, Dehly_0274, 
Dehly_0275/Dehly_0276, Dehly_0849, Dehly_0910, Dehly_1053/Dehly_1054, Dehly_1148, 
Dehly_1152, Dehly_1328, Dehly_1514, Dehly_1524/Dehly_1525, and Dehly_1530). Transcripts 
from the remaining four full-length rdhA genes (Dehly_0068, Dehly_0283, Dehly_1355, 
Dehly_1540) were not detected.  
Of the truncated rdhA genes, transcripts were detected for those lacking a predicted twin-
arginine sequence at the N-terminus (Dehly_0069, Dehly_1523, Dehly_1582), those lacking 
predicted iron-sulfur cluster binding motifs at the C-terminus (Dehly_0479), and one that lacked 
both a predicted twin-arginine sequence at the n-terminus and iron-sulfur cluster binding motifs 
at the C-terminus (Dehly_1520).  
Of the six loci where rdhA genes are accompanied by congnate rdhB genes, amplicons 
were detected using five primer sets that targeted regions spanning the rdhAB genes 
(Dehly_0156/Dehly_0157, Dehly_0275/Dehly_0276, Dehly_1053/Dehly_1054, 
Dehly_1151/Dehly_1152, Dehly_1524/Dehly_1525), indicating that the rdhAB genes are co-
transcribed by BL-DC-9
T
. The detected transcripts included the low mol% G+C rdhB gene 
predicted to code for a putative membrane anchoring protein containing two as opposed to three 
transmembrate helices (Dehly_1524). Amplification products were not detected following RT-
PCR with primers targeting the other rdhAB gene combination (Dehly_1533/Dehly_1534), 
indicating that this locus was not highly expressed or that the genes are not co-transcribed. 
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2.3.3 Expression of the transcription factors during dechlorination of different substrates 
All four transcription factors (Dehly_0120, Dehly_0270, Dehly_1149, and Dehly_1531) 
were detected in the reverse transcriptase experiments from BL-DC-9
T
 cells that were actively 
dechlorinating 1,2-DCA, 1,2-DCP, and 1,2,3-TCP. No amplicons were detected following RT-
PCR with RNA extracted from triplicate bottles prepared at the same time and incubated under 
identical conditions but without the presence of halogenated electron acceptors. No PCR 
amplicons were detected in any of the tests when RNA extract was used as template in PCR 
without reverse transcription. The agarose gel images supporting these results are presented in 
appendix C. The amplicons detected following the RT-PCR targetting the regulatory genes were 
sequenced using the BigDye Terminator version 3.1 (Applied Biosystems) in conjunction with 
an ABI prism 3130 sequencer. The sequences were aligned with the target genes from the 
genome sequence. Sequence alignments using the sequenced RT-PCR result showed that the 
right targets were detected in the RT-PCR experiments targetting the regulatory genes.  
2.4 Discussion 
It is clear from the RT-PCR results presented here that D. lykanthroporepellens BL-DC-
9
T
 simultaneously transcribes many rdh genes during the reductive dehalogenation of all three 
chlorinated alkanes tested. Simultaneous transcription of multiple rdhA genes in response to a 
single chlorinated compound has been reported previously for strains of the related genus 
Dehalococcoides (Waller et al., 2005; Fung et al., 2007; Rowe et al., 2008; Johnson et al., 2008; 
Rahm & Richardson, 2008; Wagner et al., 2009; Wagner et al., 2013). 
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Table 2.6: Summary of results from RT-PCR experiments for rdh genes with BL-DC-9
T
 grown 
with 1,2-DCA, 1,2-DCP, and 1,2,3-TCP. 
Yes=PCR amplicon of appropriate size was observed in electrophoresis gels after PCR using 
primers and annealing temperatures for various locus tag targets as summarized in Table 1. No= 
PCR amplicons of appropriate size were not detected. 
 1,2-DCA 1,2-DCP 1,2,3-TCP  
% Dechlorination 31-53% 25-65% 41-49% 
Incubation Time (Days) 8 21 24 
Daughter Products Ethene 
 
Propene 
 
Allyl 
Chloride 
RIN Number 8.5-9.2 8.4-9.6 8.4-9.4 
RNA concentration (ng/µL) 11.2-17.2 3.5-4.6 7.4-17.5 
Dehly_0068 No No No 
Dehly_0069 Yes Yes Yes 
Dehly_0075 No No No 
Dehly_0121 Yes Yes Yes 
Dehly_0156- Dehly_0157 Yes Yes Yes 
Dehly_0274 Yes Yes Yes 
Dehly_0275- Dehly_0276 Yes Yes Yes 
Dehly_0283 No No No 
Dehly_0479 Yes Yes Yes 
Dehly_0849 Yes Yes Yes 
Dehly_0910 Yes Yes Yes 
Dehly_1053-Dehly_1054 Yes Yes Yes 
Dehly_1148 Yes Yes Yes 
Dehly_1151-Dehly_1152 Yes Yes Yes 
Dehly_1328 Yes Yes Yes 
Dehly_1355 No No No 
Dehly_1514 Yes Yes Yes 
Dehly_1520 Yes Yes Yes 
Dehly_1523 Yes Yes Yes 
Dehly_1524-Dehly_1525 Yes Yes Yes 
Dehly_1530 Yes Yes Yes 
Dehly_1533-Dehly_1534 No No No 
Dehly_1540 No No No 
Dehly_1541 Yes Yes Yes 
Dehly_1582 Yes Yes Yes 
 
Simultaneous transcription of multiple rdhA genes has also been reported for mixed 
cultures that reductively dehalogenate chlorinated alkanes or alkenes (Tang & Edwards 2013; 
Tang et al., 2013). The results reported here for D. lykanthroporepellens further expand the 
diversity of bacteria known to simultaneously transcribe multiple rdh genes to include additional 
dehalorespiring species in the phylum Chloroflexi. 
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The expression pattern for rdh and regulatory genes was identical for BL-DC-9
T
 during 
dechlorination of all three chlorinated compounds, with transcripts detected for all replicates 
with primers targeting 19 of the rdh loci and transcripts not detected for any replicates using 
primers targeting six of the rdh loci (Table 3). This latter result suggests that genes with locus 
tags Dehly_0068, Dehly_0075, Dehly_0283, Dehly_1355, Dehly_1533/Dehly_1534, and 
Dehly_1540) are likely not directly involved in the dechlorination of the three tested substrates. 
They may be upregulated in presence of different halogenated substrates. It is also possible that 
these genes may have been transcribed but at levels below detection.  
The gene with locus tag Dehly_1524 has been recently identified as encoding a 1,2-DCP 
reductive dehalogenase (DcpA) based on a combination of blue native polyacrylamide gel 
electrophoresis and enzyme assays (Padilla-Crespo et al., 2014). Homologs of this gene (92% 
amino acid identity) have also been found in 1,2-DCP dechlorinating Dehalococcoides mccartyi 
cultures RC and KS (Padilla-Crespo et al., 2014). In experiments reported here, the Dehly_1524 
gene transcript was detected using RT-PCR with BL-DC-9
T
 cultures actively dechlorinating not 
only 1,2-DCP but also 1,2-DCA and 1,2,3-TCP. This leaves open the possibility that the same 
enzyme was responsible for transformation of all three halogenated alkanes.  
Two types of transcriptional regulators, MarR and two-component system transcriptional 
regulators, were found to be associated with rdh genes in the genomes of Dehalococcoides 
mccartyii strains (Kube et al., 2005; Seshadri et al., 2005). MarR mediates bacterial response to 
changes in environmental stress and metabolic conditions, usually by functioning as a repressor 
protein (Wilkinson et al., 2006). The binding of a substrate to the MarR protein results in its 
release from the promoter, thereby de-repressing transcription (Providenti & Wyndham, 2001; 
Wagner et al., 2013). The two-component system transcriptional regulators, on the other hand, 
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contain a histidine kinase, which is phosphorylated on signal recognition. The phosphorylated 
signal is subsequently transferred to a response regulator containing a C-terminal DNA binding 
domain (Galperin, 2006).  
The genome sequence shows the presence of a MarR orthologue located immediately 
upstream and in opposite orientation of RdhA Dehly_0121. Also at least three other putative 
RhdA proteins have two component system transcriptional regulators associated with them. 
These included Dehly_1148 that had Dehly_1149 (winged helix family two component system 
transcriptional regulator) with a cognate sensor signal transduction histidine kinase Dehly_1150 
interspersed between and in the same orientation to that of Dehly_1148. Dehly_0270 was 
hypothesized to be the transcriptional regulator for Dehly_0274 as blastp indicates that it is a 
member of the LuxR family of two component transcriptional regulators. It is located upstream 
and in the same orientation to that of Dehly_0274 and it also has the cognate histidine kinase 
Dehly_0269. Dehly_1530 is also hypothesized to be regulated by Dehly_1531 (LuxR family two 
component system regulator). Dehly_1531 and its cognate histidine kinase are interspersed 
between and in the same orientation of Dehly_1530. 
In the RT-PCR experiments reported here, the MarR homologue Dehly_0120 was 
detected along with transcripts from the associated rdhA (Dehly_0121) for all of the BL-DC-9
T
 
cultures growing with halogenated solvents. Transcripts from three of the two-component system 
transcriptional regulators (Dehly_0270, Dehly_1149, and Dehly_1531) were also detected along 
with transcripts from their putatively associated rdhA genes (Dehly_0274, Dehly_1148 and 
Dehly_1530). This suggests that rdhA gene regulation is mediated by both types of transcription 
factors in D. lykanthroporepellens BL-DC-9
T
.  
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2.5 Conclusion 
The simultanous transcription of many rdhA genes and the expression of the same genes 
during the dechlorination of 1,2-DCA, 1,2-DCP, and 1,2,3-TCP argues against the direct 
implication of any one gene or group of genes with a set function. As with other genome 
sequences, the rdhA genes of D. lykanthroporepellens BL-DC-9
T
 were annotated on the basis of 
sequence identity with previously annotated genes, and their actual functionality remains to be 
elucidated. As noted previously, whether proteins encoded by the rdhA genes are even involved 
with reductive dechlorination remains tenuous (Hug et al., 2013). Nevertheless, identification of 
rdhA genes and transcription regulators expressed during the dechlorination of 1,2-DCA, 1,2-
DCP, and 1,2,3-TCP sets the stage for future investigations into gene function and cell response 
to differing environmental conditions.  
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Chapter 3. Expression of 1,2-DCP reductive dehalogenase from D. lykanthroporepellens 
BL-DC-9
T
 in E. coli 
 
3.1 Introduction 
 
The experiments described in this chapter were aimed at heterologous expression of a 
1,2-dichloropropane (1,2-DCP) reductive dehalogenase enzyme from D. lykanthroporepellens 
strain BL-DC-9
T
 using E. coli as the host. Initial experiments were also conducted to develop an 
appropriate dehalogenase enzyme assay for use in assessing the catalytic activity of the 
recombinant protein. 
The reductive dehalogenase gene selected for cloning was the gene with locus tag 
Dehly_1524. As described in Chapter 2, this gene is one of the five “full length” rdhA genes with 
a cognate rdhB gene that was found to be transcribed during dechlorination of 1,2-DCA, 1,2-
DCP, and 1,2,3-TCP. Additionally, Padilla-Crespo et al. (2014) recently implicated the 
Dehly_1524 gene as encoding an enzyme (designated as DcpA) that catalyzes a 
dihaloelimination reaction in which 1,2-DCP is transformed to the product propene. Their 
identification approach combined protein assays from blue native polyacrylamide gel 
electrophoresis (BN-PAGE), SDS-PAGE separation of the proteins eluted from the gel slice 
exhibiting 1,2-DCP dechlorination activity, and LC-MS/MS analysis of the proteins separated by 
SDS-PAGE (Padilla-Crespo et al., 2014). Dehly_1524 was the only reductive dehalogenase 
associated with the gel slices based on protein fragments identified.  
The most closely related protein sequences to the DcpA of D. lykanthroporepellens BL-
DC-9
T
 (92% amino acid identity) are two putative reductive dehalogenases (GenBank accession 
numbers JX826286 and JX826287) harbored by D. mccartyi strains KS and RC, respectively. 
These Dehalococcoides strains couple growth with 1,2-DCP-to-propene dechlorination in highly 
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enriched cultures (Padilla-Crespo et al., 2014). The use of cDNA generated from KS and RC 
cultures actively dechlorinating 1,2-DCP as template in qPCR with primers targeting the dcpA 
gene showed a significant upregulation of dcpA transcripts relative to starved controls. A 
graphical depiction of the organization of the dcpA and dcpB genes in D. mccartyi strains KS and 
RC is shown in Figure 3.1. The D. lykanthroporepellens BL-DC-9
T
 dcpA and dcpB genes 
(Dehly_1524 and Dehly_1525. respectively) have similar organization and encoded features. 
 
 
Figure 3.1 Arrangement of the dcpA and dcpB genes in Dehalococcoides mccartyi strains KS 
and RC (reprinted from Padilla Crespo et al., 2014). Characteristic features encoded by the dcpA 
gene, which include a Tat signal sequence (RRDFMK) near the N-terminus and two putative 
iron-sulfur cluster binding sequences containing 3 or 4 cysteine residues toward the C-terminus 
are noted at the top. Primer binding sequences are indicated at the bottom.  
 
3.2 Materials and Methods 
3.2.1 Synthesis of dehalogenase gene construct and subcloning in expression vector 
The gene with locus tag Dehly_1524 was chemically synthesized by GenScript 
(Piscataway, NJ) with some modifications. First, the TAT signal sequence enabling transport of 
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putative membrane protein to the periplasmic space (Stanley et al., 2000) was not included in the 
gene construct. Second, the gene construct was codon optimized for the heterologous expression 
of the protein in E. coli by Jason Zhou at GenScript (NJ). The 5' flanking region was provided 
with the restriction site for NdeI 'CATATG' with the start codon in bold. Also, a BamHI site 
'GGATCC’ was included after the termination codon of the gene. The gene construct was 
subcloned in the BamHI and NdeI sites of the expression vector pET-16b (Novagen, Madison, 
WI, see Appendix D2 for plasmid map). The expression vector carries an isopropyl β-D-1-
thiogalactopyranoside (IPTG) inducible promoter and a gene for ampicillin resistance. The gene 
was cloned in-frame with an N-terminal His Tag that is encoded by the expression vector. The 
subcloning in the pET-16b vector was verified by restriction digestion and gel electrophoresis at 
GenScript. The full-length, codon-optimized gene construct sequence and the original gene 
sequence are provided in Appendix D. 
3.2.2 Development of dehalogenase enzyme assay using Dehalogenimonas 
lykanthroporepellens BL-DC-9
T
 cells 
The dehalogenase enzyme assay was adapted from an assay that was originally developed 
by Holscher et al. (2003) and recently used by Tang et al. (2012). D. lykanthroporepellens BL-
DC-9
T
 cells were grown in the presence of 0.5 mM 1,2-DCP as the electron acceptor using 
medium and incubation conditions as described by Maness et al. (2012). D. lykanthroporepellens 
BL-DC-9
T
 cells were collected by centrifugation of 400 mL of cell culture at 5,900×g at 4 °C for 
30 minutes. Centrifugation was done in batches of 50 mL cell culture in plug sealed 50 mL 
centrifugation tubes (Corning). Working inside an anaerobic chamber (Coy) supplied with gas 
comprised of 10% H2, 10% CO2, and 80% N2 (vol%), clarified supernatant was removed using a 
25 mL pipette, leaving about 1 mL of culture in each centrifugation vial. The centrifugation vials 
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were vortexed to resuspend the pellets, and then the 1 mL re-suspended aliquots from eight 
centrifuge tubes were combined in a single 50 mL centrifugation tube. This was followed by 
another round of centrifugation at 5,900×g at 4 °C for 30 minutes. The supernatant was discarded 
after the centrifugation to obtain a cell pellet. Cell pellets were resuspended in 250 µL of 4× 
Sample prep Buffer (Native Gel Sample Prep Kit, Invitrogen, Cat. No. BN2008) containing 1% 
digitonin for detergent cell lysis. The resuspended cells were transfered to bead beating tubes 
from an UltraClean Microbial DNA Isolation Kit (MoBio Laboratories, Cat#12224-250-BT). 
The resuspended cells were lysed by mechanical sheering in a horizontal shaker (Vortex Genie 2 
at 3,200 rpm) with two minutes of shaking followed by one minute of incubation on ice. This 
cycle was repeated three times. After this step the bead beating tubes were transferred inside the 
anaerobic chamber and for the enzyme assay, 20 µL of cell lysate was added to 3 mL of assay 
buffer [100 mM Tris HCl, 2 mM methyl viologen, and 0.5 mM 1,2-DCP] supplemented with 
titanium citrate solution [(Zehnder and Wuhrmann, 1976), 0.5 mL per 100 mL of assay buffer, 
resulting in a final concentration of 0.3 mM titanium and 0.9 mM citrate]. For comparison 
purposes, in the assay used by Tang et al. (2012), the final concentration of titanium citrate was 2 
mM and a chlorinated substrate concentration of 30-70 mg/L was used.  For preparation of the 
titanium citrate solution, 11.9 g of sodium citrate·2H2O was dissolved in 227 mL of water. The 
dissolved sodium citrate solution was transfered into an anaerobic chamber, and then 3.0 g of 
titanium chloride was added and mixed by swirling using a 25 mL serological pipette. The 
mixture was then distributed to 50 mL centrifuge tubes, taken out of the anaerobic chamber, and 
centrifuged at 8,000×g for 20 minutes. Following centrifugation, the supernatant was filter 
sterilized while working inside the anaerobic chamber and then it was stored in sealed sterile 
glass 160 mL serum bottles until use.  
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The enzyme assays were set up in 12 mL amber colored serum vials. After adding the 
cell lysate, the vials were sealed with butyl rubber stoppers and aluminum crimp caps and 
incubated inside the anaerobic chamber for 24 hours at 30 °C. Identical enzyme assays were also 
set up but without adding the cell lysate (negative control) and also using the supernatant 
(soluble fraction) collected after centrifugation of the cell lysate. After adding the cell lysate in 
the assay vials inside the anaerobic chamber the bead beating tubes were tightly capped and 
taken outside of the anaerobic chamber for centrifugation at 4000×g for two minutes. The bead 
beating tubes were taken back in the anaerobic chamber and 50 µl of the supernatant was also 
used in the enzyme assay to check if the enzyme activity was present both in the soluble and 
insoluble fractions. Following incubation, a 100 µL aliquot of gas headspace was collected from 
each serum bottle using a glass gas-tight syringe (Pressure-Lok, VICI Precision Sampling). Gas 
samples were then introduced by direct injection to a gas chromatograph (Agilent 7820A) 
equipped with a flame ionization detector (FID). Activity was assessed by measuring propene 
production and decrease in percentage of 1,2-DCP in bottles receiving cell lysates relative to 
negative controls.  
3.2.3 Transformation of the expression vector into host cells  
The codon-optimized gene construct Dehly_1524 cloned in the pET-16b expression 
vector (Novagen) was transformed in BL21(DE3)pLysS (Novagen) chemically competent E. 
coli. Cells were transformed by adding 1 µL of the plasmid solution (10 ng/µL concentration) to 
the solution containing BL21(DE3)pLysS cells. The mixture of cells and DNA was transferred to 
a water bath at 42 °C for 30 seconds and then shifted to an ice bath and incubated for 5 minutes. 
SOC media was added to the cells, and the cells were incubated at 37 °C for 60 minutes in a 
rotating shaker shaking at 250 rpm. The SOC media was used from BL21(DE3)pLysS singles kit 
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(Novagen Cat. No.70232-3). Following incubation, 25 and 50 µL aliquots of the cells were 
plated on LB agar plates containing 50 µg/mL ampicillin, 34 µg/mL chloramphenicol, and 1% 
glucose. The plates were incubated overnight at 37 °C and then visually inspected for the 
appearance of colonies.  
3.2.4 Induction and overexpression of the protein 
For a small scale protein induction, a single colony was picked and inoculated in 3 mL 
LB broth in a 10 mL falcon tube with 50 µg/mL ampicillin and 34 µg/mL chloramphenicol. The 
LB was also supplemented with 2× vitamin mix [4-aminobenzoic acid 40 mg, D(+)-Biotin 10 
mg, nicotinic acid 100 mg, calcium D(+)-pantothenate 50 mg, pyridoxine dihydrochloride 150 
mg dissolved in 500 mL of sodium phosphate buffer (10mM: pH 7.1)], 2× thiamine mix [100 mg 
thiamine chloride dihydrochloride dissolved in 500 mL of sodium phosphate buffer (25 mM; pH 
3.4)], and 2× vitamin B12 solution (50 mg cyanocobalamine in 500 mL distilled water) (0.5 mL/L 
concentration for each).  
To reach the exponential phase of cell growth, the cells were incubated overnight at 37 
°C in a rotating shaker shaking at 250 rpm. The following day, 50 µL of the dense cell culture 
was inoculated into fresh 3 mL LB broth supplemented with the same amendments as before and 
incubated at 37 °C for 3 hours in a rotating shaker shaking at 250 rpm. After 3 hours, cultures 
were split into two parts each having 1.5 mL volume. One of these was induced by adding 3 µL 
of 0.5 M IPTG (isopropyl β-D-1-thiogalactopyronaside) solution resulting in a final IPTG 
concentration of 1 mM. The induced and non-induced cultures were further incubated at 37 °C in 
a rotating shaker at 250 rpm for two more hours. Cells from the non-induced and induced cell 
cultures were collected by centrifugation at 8,000×g for 1 minute. Cells were resuspended in 500 
µL 4× Sample prep Buffer (Native Gel Sample Prep Kit, Invitrogen, Cat. No. BN2008) 
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containing 1% digitonin for detergent cell lysis. The resuspended cells were transferred to bead 
beating tubes from an UltraClean Microbial DNA Isolation Kit (MoBio Laboratories, 
Cat#12224-250-BT). The resuspended cells were lysed by mechanical sheering in a horizontal 
shaker (Vortex Genie 2 at 3,200 rpm) with four cycles each consisting of two minutes of shaking 
followed by one minute of incubation on ice. Enzyme assays were set up using the E. coli cell 
lysates the same way that were used for the D. lykanthroporepellens BL-DC-9
T
 cells with 1,2-
DCP as substrate (see Section 3.2.2).  
3.2.5 Induction experiments to obtain the protein in the soluble fraction and prevent 
protein misfolding 
As described in the Results section of this chapter, the protein expressed by transformed 
E. coli cells under the conditions described above in Section 3.2.4 was not observed to have 
catalytic activity under the conditions tested, and the bulk of the recombinant protein was found 
to be associated with the insoluble fraction of cell lysates. In an attempt to increase the solubility 
of the protein and obtain the protein in a catalytically active form, experiments were performed 
using a variety of alternate induction conditions. These experiments included different induction 
temperatures, induction times, and IPTG concentrations as described in the following sub-
sections. 
3.2.5.1 Different induction temperatures 
To explore whether induction at a temperature lower than the initially tested temperature 
of 37 °C would lead to production of a soluble and/or catalytically active dehalogenase, 
additional experiments were carried out with induction at 23 °C. Two tubes each containing 3.0 
mL culture with antibiotics were inoculated from a single clone of transformed cells. After 2 
hours of incubation at 37 °C, the culture volumes were each divided equally into two separate 
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tubes (resulting in 4 tubes total, each containing 1.5 mL culture) and 3 µL of 0.5 M IPTG was 
added to each of the four tubes and induced for 6 hours at 23 °C. After induction, the cells were 
collected by centrifugation at 8,000×g for 1 minute. The soluble and insoluble cell lysate were 
prepared using the BugBuster protein extraction reagent protocol (Novagen Cat. No.70584-
3).The insoluble and the soluble fraction was analyzed by 12% SDS-PAGE (Mini-PROTEAN 
TGX Gels, BIO-RAD). The gels were run at 200 Volts for 45 minutes. 10× Tris/Glycine/SDS 
Buffer was used as the running buffer (BIO-RAD Cat. # 161-0732). Following electrophoresis, 
the gels were stained using 50 mL of Bio-Safe Coomassie G-250 stain (Biorad Cat. # 161-0786) 
for 45 minutes in a slow moving shaker. After staining, the gel was transferred to 50 mL 
deionized water and incubated in a slow moving shaker for about two hours till the bands started 
to appear. 
 In a separate experiment, induction was carried out at 18 °C. Two tubes of 3 mL culture 
with antibiotics were inoculated with a single clone of transformed cells. After 2 hours of 
incubation at 37 °C, the cultures were split apart and 3 µL of 0.5 M IPTG was added to each of 
the four tubes and induced for 10 hours at 18 °C. The longer incubation period for induction at 
18°C (10 hours) was longer than that for induction at 23 °C (6 hours) and the initial base-line test 
at 37 °C (2 hours). After induction, the crude cell extract and the soluble fraction was analyzed 
by 12% SDS-PAGE as described above. 
3.2.5.2 Different IPTG concentrations 
To explore whether induction with an IPTG concentration different from the initial test 
(which involved addition of 3 µL of 0.5 M IPTG per 1.5 mL culture volume, final concentration 
1 mM) would lead to production of a soluble and/or catalytically active dehalogenase, additional 
experiments were carried out with induction using lower IPTG concentrations. Two tubes of 3 
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mL culture with antibiotics were each inoculated with a single clone of transformed cells. After 2 
hours of incubation at 37 °C, the cultures were divided and 3 µL aliquots of IPTG solution 
containing three different concentrations (0.1 M, 0.2 M, and 0.3 M) was added to the three tubes, 
which were induced for 2 hours at 37 °C (final IPTG concentrations ranging from 0.6 mM to 0.2 
mM). After induction, the crude cell extract and the soluble fraction was analyzed by 12% SDS-
PAGE. 
3.2.5.3 Different induction times 
To explore whether induction at a temperature of 37 °C but with a shorter induction time 
would lead to production of a soluble and/or catalytically active dehalogenase, additional 
experiments were carried out with alternate durations of incubation following IPTG addition 
prior to cell harvest. Two tubes of 3 mL culture with antibiotics were inoculated with a single 
clone of transformed cells. After 2 hours of incubation at 37 °C, the two cultures were each 
divided equally into separate tubes (four tubes total). Then, 3 µL 0.5 M IPTG was added to each 
of the four tubes and the cultures were induced for four different time durations (0.5, 1.0, 1.5, 
and 2.0 hours) at 37 °C. After induction, crude cell lysates and the soluble fractions were 
analyzed by 12% SDS-PAGE. 
3.2.6 Protein refolding and enzyme assay  
As described in the Results section of this chapter, the protein expressed by transformed 
E. coli cells under the conditions described above in Section 3.2.5 was not observed to have 
catalytic activity under the conditions tested. In an attempt to obtain the protein in a catalytically 
active form, experiments were performed to refold the protein from the insoluble fraction and 
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check the refolded protein for catalytic activity. Inculsion bodies were first purified from the 
insoluble fraction and refolding was attempted as described in the following subsections.  
3.2.6.1 Preparation of inclusion bodies for protein refolding  
100 mL of LB broth with antibiotics was innoculated with 1% v/v culture of transformed 
cells. After three hours of growth at 37 °C the cells were induced with IPTG resulting in a final 
concentration of 1mM. The induced cultures were further incubated at 37 °C in a rotating shaker 
at 250 rpm for two more hours. The induced cells were harvested by centrifugation at 10,000×g 
for 10 min using a weighed centrifuge tube. The harvested cell pellets were resuspended in 5 mL 
of BugBuster reagent (Novagen). After resuspension in BugBuster reagent, a majority of the 
steps were carried inside the anaerobic chamber to prevent oxygen exposure to the induced 
protein. The resuspended cells were incubated on a rotating shaker at a slow setting for 10-20 
minutes at room temperature. Inclusion bodies were prepared following the BugBuster protein 
extraction reagent protocol (Novagen Cat. No.70584-3). After the incubation of the cell pellet 
with BugBuster reagent, the insoluble cell debris was removed by centrifugation at 16,000×g for 
20 minutes at 4 °C. The pellet obtained after centrifugation was resuspended in the same volume 
of BugBuster reagent that was used to resuspend the original cell pellet. Resuspension was 
accomplished by complete vortexing. This was followed by an incubation of 0.5 hour, and then 
an equal volume of 1:10 diluted BugBuster reagent diluted in nuclease-free water was added to 
the suspension and mixed. The cell suspension was then centrifuged at 5,000×g for 15 min at 4 
°C. Inclusion bodies were collected as the precipitate. The inclusion bodies were washed by two 
more rounds using 1:10 diluted BugBuster reagent diluted in nuclease-free water. The inclusion 
body suspension was analyzed by 12% SDS-PAGE, and the washed inclusion body pellets were 
stored at -80 °C until refolding. 
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3.2.6.2 Solubilization of inclusion bodies 
The inclusion bodies were solubilized according to the recommended protocol from the 
Pierce
TM
 Protein Refolding kit employed for subsequent refolding (see Section 3.2.6.3). Briefly, 
the inclusion body pellet was dissolved in 1 mL of 6-8 M guanidine hydrochloride, 50 mM Tris 
(pH 8.0). The suspension was vortexed to obtain a homogenized suspension. The suspension was 
incubated overnight at 4 °C to completely dissolve the inclusion body. After the overnight 
incubation, insoluble components were removed by centrifugation at 10,000×g for 20 minutes, 
and the supernatant was collected. The concentration of protein in the supernatant was quantified 
using a Qubit 2 protein assay kit (Life Technologies). 
3.2.6.3 Refolding protocol  
Protein refolding was attempted using a Pierce
TM
 Protein Refolding Kit (Life 
Technologies, Cat. No. 89867). The refolding kit includes nine different buffers that provide a 
wide range of protein denaturing conditions. According to the manufacturer’s protocol, the 
buffers provide nine different denaturation conditions that range from 0-1.4 M guanidine and 0-
0.80 M arginine. Table 3.1 shows the matrix set up for the initial protein refolding screening 
experiment. Table 3.2 summarizes the secondary screening experiments for refolding in the 
presence of polyethylene glycol. The refolding reactions were set up inside the anaerobic 
chamber in 2 mL microcentrifuge tubes containing 900 µL aliquots of the base refolding buffers 
along with EDTA, reduced glutathione, oxidized glutathione, and water (Tables 3.1 and 3.2). 
The refolding buffer was also supplemented with 2× Vitamin mix, 2× Thiamine mix, and 2× 
Vitamin B12 solution (0.5 mL/L, concentration details about the vitamins provided in Section 
3.2.4). The refolding tubes and the denatured protein solution was placed on ice. 10 µL of 
protein solution was added to each refolding tube, and after the addition, the tubes were vortexed 
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and immediately placed on ice. This was repeated until 50 µL of protein solution was added to 
each refolding tube. The refolding tubes were incubated for 24 hours at 4°C. The refolding tubes 
were transferred to 30 °C water bath for 2 hours, and then a fraction of the solution was analyzed 
for refolding using the dehalogenase enzyme assay described in Section 3.2. 
Table 3.1 Tabular Representation of the Refolding Reaction tubes. First screening for refolded 
proteins in the presence of denaturing concentration, reducing environment and protein 
concentration.  
Tube ID Base 
Refolding 
Buffer ID No. 
Volume 100 
mM EDTA 
(µL) 
Volume 200 
mM GSH 
(µL) 
Volume 100 
mM 
GSSH  
(µL) 
Volume H2O 
(µL) 
Volume 0.5-
1.0 mg/mL 
protein stock 
(µL) 
1 1 10 10 2 28 50 
2 2 10 10 4 26 50 
3 3 10 5 10 25 50 
4 4 10 10 4 26 50 
5 5 10 5 10 25 50 
6 6 10 10 2 20 50 
7 7 10 5 10 25 50 
8 8 10 10 2 28 50 
9 9 10 10 4 26 50 
GSH-Reduced Glutathione 
GSSH-Oxidized Glutathione 
 
Table 3.2 Refolding screening in the presence of polyethylene glycol  
Tube ID Refolding 
Buffer using 
buffers with 
buffer ID nos 
6 and 4  
(900 µL) 
Volume 
100 mM 
EDTA  
(µL) 
Volume 
200 mM 
GSH 
 (µL) 
Volume 
100 mM 
GSSG  
(µL) 
Volume 10 
mM PEG  
(µL) 
Volume 
H2O  
(µL) 
Volume 
0.5-1.0 
mg/mL 
protein 
stock (µL) 
1 6 10 10 2 0 28 50 
2 6 10 10 2 6.7 21.3 50 
3 6 10 10 2 13.3 14.7 50 
4 6 10 10 2 20 8 50 
5 4 10 10 2 0 28 50 
6 4 10 10 2 6.7 21.3 50 
7 4 10 10 2 13.3 14.7 50 
8 4 10 10 2 20 8 50 
PEG-Polyethylene Glycol (polymer that blocks aggregation during refolding) 
GSH-Reduced Glutathione, GSSG-Oxidized Glutathione 
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3.2.7 Experiments to adress potential reductive dehalogenase ligand binding issues 
As described in the Results section of this chapter, the protein refolding described above 
in Section 3.2.6 was not observed to result in catalytic activity of the recombinant protein under 
the conditions tested. In an attempt to obtain the protein in a catalytically active form, further 
experiments were performed to address potential reductive dehalogenase ligand binding issues 
by mixing the cells lysates of the induced E. coli cells with cell lysates from Dehalogenimonas 
alkenigignens IP3-3
T
 cells. 
400 mL of D. alkenigignens IP3-3
T
 cells actively dechlorinating 1,2-DCP were collected 
by centrifugation at 5900×g at 4 °C for 30 minutes. The centrifugation was done in batches of 50 
mL cell culture in plug sealed 50 mL centrifugation tube (Corning). The supernatant was 
discarded using a 25 mL pipette leaving about 1 mL of culture in the centrifugation vial inside 
the anaerobic chamber. Approximately 8 mL of culture was collected after the first 
centrifugation step, and the culture was centrifuged again at 3,500 rpm (5,900×g) at 4 °C to 
obtain the cell pellet. The cell pellets were resuspended in 250 µL of 4× Sample prep Buffer 
(Native Gel Sample Prep Kit, Invitrogen, Cat. No. BN2008) containing 1% digitonin for 
detergent cell lysis. The resuspended cells were lysed by mechanical sheering in a horizontal 
shaker. The cell lysis was accomplished by two minutes of shaking followed by one minute of 
incubation on ice. At the same time, a medium scale protein induction was set up using 50 mL of 
induced cell culture. 10 µL of 0.5 M IPTG was used for inducing 50 mL of transformed E. coli 
cell culture having Dehly_1524 cloned in pET-16b expression vector (Novagen). The induction 
was carried out at 37 °C in a rotating shaker at 250 rpm for two more hours. The induced cells 
were harvested by centrifugation at 10,000×g for 10 minutes using a weighed centrifuge tube. 
The harvested cell pellets were resuspended in 5 mL of BugBuster reagent (Novagen). The 
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resuspended cells were incubated on a rotating shaker at a slow setting for 10-20 minutes at room 
temperature. The crude cell lysates of D. alkenigignens IP3-3
T
 and the E. coli cells were mixed 
in the ratio 1:1, and 50 µL of the mixture was used for the dehalogenase enzyme assay described 
in Section 3.2.2. As a control, 50 µL of crude cell lysate of D. alkenigignens IP3-3
T
 cells were 
also used in the dehalogenase enzyme assay.  
3.3 Results 
3.3.1 Enzyme assay results with D. lykanthroporepellens BL-DC-9
T
 cell lysate 
Triplicate experiments were set up, and dechlorination activity was monitored after 
overnight incubation of the assay vials by headspace GC analysis. 10-15% dechlorination was 
observed consistently after overnight incubation in vials with the crude cell lysate added. No 
dechlorination was observed in assay vials with the cell supernatant, indicating enzymatic 
activity to be present in the insoluble cell fraction. Negative control assay vials that did not 
receive part of the cell lysate also did not exhibit dechlorination. The assay developed was 
subsequently used in the detection of dehalogenase activity of the induced dehalogenase protein 
in recombinant E. coli. 
3.3.2 Transformation results 
The LB agar plates having 50 µg/mL ampicillin, 34 µg/mL chloramphenicol, and 1% 
(m/v) glucose were incubated overnight and then visually inspected for the appearance of 
colonies. Transformed BL21(DE3)pLysS cells were observed the following day on the selection 
plates. 
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3.3.3 Expression of the 1,2-DCP reductive dehalogenase protein from D. 
lyknathroporepellens BL-DC-9
T
 in E. coli  
In the initial experiment (induction with IPTG at a final concentration of 1 mM at 37°C 
for 2 hours) to check for the expression of the induced DcpA protein in tranformed E. coli, a 
fraction of the induced and uninduced cell culture was analyzed by 12% SDS-PAGE. The bulk 
of the expected sized protein fragment of 53 kDa was detected in the insoluble fraction of cell 
lysates (Figure 3.3). 
 
 
 
Figure 3.2 SDS-PAGE analysis of the transformed E. coli. Lanes 1, 3 and 5: cell lysate generated 
after after induction with 1 mM IPTG for two hours. Lanes 2, 4, and 6: cell lysate generated from 
uninduced cells grown under identical conditions. Lanes 7, 8, and 9: soluble fraction of cell 
lysate generated after after induction with 1 mM IPTG for two hours. 25 µL of cell extract was 
mixed with 25 µL of loading buffer, and the resulting 50 µL aliquot was loaded for lanes 1-9. 
Different lanes represent separate replicates. Lane M: 10 µL of Precision Plus Prestained All 
Blue Protein Standard (Biorad).  
3.3.4 Enzyme assay results from the induced proteins 
For initial “small scale (10 mL cultures)” enzyme assays using different volumes of 
induced E. coli cells in 10 mL total volume induced at a final IPTG concentration of 1 mM for 2 
10 kDa 
53 kDa 
250 kDa 
        M           1             2             3            4            5              6             7              8           9    
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hours at 37°C, no dechlorination activity was observed. To investigate whether a large culture 
volume would yield activity, a “medium scale (50 mL culture)” protein induction was set up 
using 50 mL of induced cell culture with the same induction conditions; however, no enzyme 
activity was observed from 50 mL of induced cells. To check whether induction was successful, 
a fraction of the induced cell culture was analyzed by 12% SDS-PAGE (shown in Figure 3.3). 
The expected sized protein was observed in the SDS-PAGE analysis in the insoluble fraction. 
Similarly, a “large scale (200 mL and 500 mL culture)” induction was also set up using 200 mL 
and 500 mL of induced cell culture (again with the same induction conditions), and still enzyme 
activity was not observed using the dehalogenase enzyme assay. 10-15% dechlorination was 
consistently observed in positive controls with cell lysates from D.lykanthroporepellens BL-DC-
9
T
.   
Using alternate induction conditions as described in Sections 3.2.5.1 to 3.3.5.3 had little 
effect in increasing the protein solubility, and the majority of the recombinant protein was 
consistently detected in the insoluble fraction. Expression of the protein was detected primarily 
in the insoluble fraction even when the expression was attempted at lower temperatues of 23 °C 
at a final IPTG concentration of 1 mM (see Figure D1 in Appendix D). When induction was 
attempted at shorter induction times of 0.5 hours, 1 hours, and 1.5 hours at 37 °C at a final IPTG 
concentration of 1 mM, it was consistently found to be expressed in the insoluble fraction in bulk 
(see Figure D2 in Appendix D). Expression of the protein was again observed mainly in the 
insoluble fraction when induction was attempted at lower final IPTG concentrations of 0.2 mM 
to 0.6 mM at 37 °C (see Figure D3 in Appendix D). 
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3.3.5 Enzyme assay results from the protein refolding and ligand binding experiments 
 After the enzyme assays from the “large scale” induction experiments (employing 500 
mL culture volume with induction at the base-line conditions of 1mM IPTG did not show 
dehalogenase activity, additional experiments were undertaken in an attempt to refold the 
potentially mis-folded protein. After the inclusion bodies were prepared using the Inclusion 
Body Preparation protocol from the BugBuster protein extraction reagent (Novagen) a small 
fraction of the purified inclusion bodies were analyzed using 12% SDS-PAGE. The remaining 
inclusion body was solubilized using 1 mL of 6-8 M Guanidine Hydrochloride, 50 mM Tris (pH 
8.0). The concentration of protein that was present in the solubilized inclusion body was found to 
be 3,000 ng/µL as estimated by Qubit assay (Life Technologies). Dehalogenase enzyme activity 
was not observed from any of the refolded protein solution tubes.  
For the dehalogenase enzyme assay from the “large scale” induction experiments 
employing base-line conditions (500 mL culture volume, induction at 1 mM final IPTG 
concentration], 750 µg of protein (crude lysate) was applied in the assay. The Mac Nelly et al. 
(2014) group also used a similar range of 250-750 µg of protein (crude lysate) in the 
dehalogenase assay that was successful in detecting PceA dehalogenase activity after protein 
expression in S. blattae. In the assays from the refolding experiments reported in this chapter, 
however, 50 µg of protein was applied in the assay. In the most recent success at producing a 
functional dehalogenase using E. coli, a very high concentration of purified and cofactor-
reconstituted vinyl chloride reductive dehalogenase was tested; a concentration of 0.2-1.0  
mg/mL (with 6 mL per assay bottle) was shown to exhibit dehalogenase activity (Parthasarathy 
et al., 2015). 
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Figure 3.3 SDS-PAGE analysis after inclusion body purification. Predominantly a prominent 
band of expected size is seen in the lane 2 with purified inclusion body. Lane 3 is the induced E. 
coli cell lysate induced at 37 °C using a final IPTG concentration of 1 mM, and lane 4 is the 
uninduced cell lysate grown at 37 °C. Lane 1 is the Precision plus Protein standard (Biorad). 
For the enzyme assays using mixtures of induced lysates of E. coli and D. alkenigignens 
IP3-3
T
, approximately 50% or less enzyme activity was observed in the dehalogenase enzyme 
assay when the lysates of E. coli and D. alkenigignens IP3-3
T
 were mixed in the ratio 1:1 in 
comparison to the positive controls using only BL-DC-9
T
 cell lysate. 
3.4 Discussion 
At the time when functional expression of the 1,2-DCP reductive dehalogenase protein 
was attempted in experiments described in this dissertation chapter, a genetic system for the 
functional expression of dehalogenase enzymes was unknown. Hence, the expression was 
attempted using the standard host E. coli. Extreme oxygen sensitivity of this family of proteins 
makes the characterization of the dehalogenase protein challenging (Mac Nelly et al., 2014). The 
        4            3             2            1 
53 kDa purified inclusion body 
10 kDa 
250 kDa 
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gene was synthesized without the TAT signal sequence based on the rationale that it would be 
preferable to locate the functional protein inside the cytoplasm of the E. coli cells and thereby 
prevent it from reaching the oxygen rich periplasmic space of E. coli. The gene was codon 
optimized for expression in E. coli cells. The 53 kDa 1,2-DCP reductive dehalogenase protein 
was found to be expressed consistently in E. coli cells. In all attempts described in this chapter, 
however, the bulk of the protein was expressed in the insoluble fraction, and it was found to be 
catalytically inactive. The protein was consistently expressed in the insoluble fraction in spite of 
using lower induction times and lower IPTG concentrations for the induction. Solubility was not 
appreciably enhanced and catalytic activity was not detected when induction was carried out at 
lower temperature of 23 °C and 18 °C.  
It is possible that the TAT signal sequence is involved in protein folding, and removing 
the TAT signal sequence may have resulted in the protein misfolding causing the protein to be 
expressed in the insoluble fraction. Enzyme activity for positive controls (D. 
lykanthroporepellens BL-DC-9
T
) were also observed only with the insoluble fractions of crude 
cell lysates; enzyme activity was absent when the cell lysate was centrifuged and the supernatant 
was used in the enzyme assays. The protein may simply not be soluble. Also, in spite of using 
cobamides in the LB media during expression of the protein, the protein was not expressed 
functionally. All attempts to refold the protein from the insoluble fraction did not produce a 
catalytically active protein. 
In previously reported attempts of expression of a functional dehalogenase in E. coli, the 
absence of a de novo cobamide biosynthesis pathway was speculated to be a likely reason for the 
failure to produce a functional protein (Suyama et al., 2002, Sjuts et al., 2012. This is further 
supported by the fact that the first report of a functional dehalogenase production heterologously 
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was in the cobamide producing Shimwellia blattae cells (Mac Nelly et al., 2014). This study 
reported that both 5,6-dimethylbenzimidazole and adeninyl-cobamides function as lower ligand 
cofactors for the PceA reductive dehalogenase and a certain level of endogenous cobamide is 
essential for the production of a functional dehalogenase enzyme. Cobamide extraction and 
analysis in this study showed that the S. blattae cells could produce pseudo-B12 that has 
dimethylbenzimidazole or adeninyl as the lower ligand (Mac Nelly et al., 2014). Also, when 
externally 5,6-dimethylbenzimidazole was added it possibly replaced adeninyl as the lower 
ligand and thereby increased cobamide production and the enzyme activity. It has been very 
recently reported that the crystal structure of the NprdhA reductive dehalogenase indicates a 
mechanism of cobamide dependent dehalogenation (Payne et al., 2015). Functional expression of 
the NprdhA protein was not detected in E. coli, again possibly due to the lack of cobalamin 
(Payne et al., 2015). The NprdhA lacks the TAT signal sequence indicating that it is a 
cytoplasmic protein and this was expressed successfully in the soluble fraction in E. coli, 
however, catalytic activity was not observed (Payne et al., 2015). This indicates that presence of 
the cobalamin cofactor is necessary for functional activity even when the protein is not misfolded 
and expressed in the soluble fraction. The first chapter of the dissertation mentions the 
significance of the cobamides in the dehalogenation chemistry. Reduction of the neutral 
cobalt(II) of the cobalamin to the superactive cobalt(I) form is likely to be an important step in 
the dehalogenation mechanism, and the lower ligand at the active site of the enzyme may carry 
out this conversion (Bommer et al., 2014). Since the E. coli cells lack a pathway for catabolic 
metabolism (Lawrence et al., 1996) that are cobamide dependent it can be concluded that 
production of a nonfunctional enzyme in E. coli is possibly due to to the lack of the cobamide 
synthesis pathway. The expression of the non-functional 1,2-DCP reductive dehalogenase 
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protein in BL21(DE3)pLysS E. coli cells is consistent with the notion that a de novo cobamide 
biosynthesis pathway is essential for maturation (catalytic activity) of the dehalogenase enzyme.  
All characterized reductive dehalogenases have cobamide binding sites. The cobamides 
are members of vitamin B12 family that are produced in prokaryotes, and these cobamides play 
important role in regulation of gene expression in prokaryotes (Hazra et al., 2013). The main 
differences in the cobamides produced by the different organisms are in the structure of the 
lower axial ligand. To investigate whether the inactive form of the enzyme might be due to a 
difference in ligand binding, cell lysates of E. coli and D. alkenigignens IP3-3
T
 were mixed in 
the ratio 1:1 (v/v) and subjected to the dehalogenase enzyme activity assay. Dehalogenase 
enzyme activity in the mixture of induced E. coli and D. alkenigignens IP3-3
T
 was 
approximately 50% less in comparison to the positive controls, indicating that mixing the E. coli 
and D. alkenigignens IP3-3
T 
lysates did not produce a functionally active enzyme. This could be 
because the cobamide cofactor must be available during protein synthesis and folding. Also it is 
a possibility that cobamide production in D. alkenigignens IP3-3
T
 is different from the cobamide 
usage needed for the functional activity of DcpA in D. lykanthroporepellenss BL-DC-9
T
.   
3.5 Conclusions 
The codon optimized 1,2-DCP reductive dehalogenase protein from D. 
lykanthroporepellens strain BL-DC-9
T
 was non-functionally expressed using E. coli as the host. 
The majority of the recombinant protein was expressed in the insoluble fraction. Dehalogenation 
activity was also associated with the insoluble fraction of D. lykanthroporepellens strain BL-DC-
9
T
,
 
suggesting that the protein is poorly soluble, even if assembled with the appropriate cofactors. 
Attempts to refold the protein and mixing the E. coli and D. alkenigignens IP3-3
T
 cell lysate did 
not show an increase in functional enzyme activity, perhaps because the cobamides available 
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differed from the cobamide variant synthesized by D. lykanthroporepellens strain BL-DC-9
T
. 
Based on the now well-documented requirement for a cobamide cofactor for dehalogenation 
activity, the standard genetic system of E. coli is unlikely to be a suitable host for the functional 
production of this dehalogenase.  
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Chapter 4. Expression of 1,2-DCP reductive dehalogenase from Dehalogenimonas 
lykanthroporepellens BL-DC-9
T
 in S. blattae DSM 4481
T
4.1 Introduction 
As described in Chapter 1 (see Section 1.6), Shimwellia blattae DSM 4481
T
 has been
recently reported to contain a genetic system that was successful in heterologous expression of 
catalytically active RdhA proteins from Desulfitobacterium hafniense strain Y51 and D. 
hafniense DCB-2. The tetrachloethene reductive dehalogenase (PceA) of the Desulfitobacterium 
hafniense strain Y51 was functionally expressed in the S. blattae cells. The active RdhA3 from 
D. hafniense DCB-2 was also expressed in Shimwellia blattae DSM 4481
T
 and the recombinant
enzyme exhibited the conversion of 3,5-dichlorophenol,2,3-dichlorophenol and 2,4-
dichlorophenol (Mac Nelly et al., 2014). The experiments described in this chapter were aimed 
at extending on this previous finding with the functional expression of a 1,2-DCP reductive 
dehalogenase enzyme from D. lykanthroporepellens strain BL-DC-9
T
 using S. blattae DSM
4481
T
 as the host.
4.2 Materials and Methods 
4.2.1 Synthesis of dehalogenase gene construct and subcloning in expression vector 
The gene sequence with locus tag Dehly_1524 was chemically synthesized at GenScript 
(NJ). In contrast with the approach employed in experiments described in Chapter 3, the TAT 
signal sequence essential for the transport of membrane proteins to the periplasmic space was 
included in the gene construct. This was based on the rationale that three previous studies have 
shown that it might be essential for proper folding of the Rdh protein (Sjuts et al., 2012; Malliard 
et al., 2011; Mac Nelly et al., 2014). The 5' flanking region was provided with the restriction site 
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for EcoRI 'GAATTC'. Also, a BamHI site 'GGATCC' was included after the termination codon 
of the gene. Codon optimization was not performed for expression in S. blattae as the functional 
PceA from Desulfitobacterium hafniense strain Y51 was expressed in S. blattae without codon 
optimization. The gene construct was subcloned in the EcoRI and BamHI site of the expression 
vector pASK-IBA 37 Plus (IBA-Germany, See Appendix E2 for plasmid map and sequence of 
the cloned gene). The gene was cloned in frame with an N-terminal His Tag that is encoded by 
the expression vector. The subcloning in the expression vector was verified by restriction 
digestion and gel electrophoresis at GenScript. The expression vector carries a tetracycline 
inducible promoter for the expression of cloned target proteins and a gene for ampicillin 
resistence. 
For co-expression along with the DcpA protein. the PceT gene from Desulfitobacterium 
hafniense strain Y51 (trigger factor that has shown to increase the solubility of PceA protein in S. 
blattae cells, Mac Nelly et al., 2014) (GenBank Accession AP008230 region "complement 
3227661-3228617") was chemically synthesized at Genscript (Piscataway, NJ) and subcloned in 
the EcoRI and BamHI cloning sites of of the expression vector pASK-IBA 3C (IBA-Germany, 
See Appendix E2 for vector map). The gene was cloned in-frame with a C-terminal Strep Tag 
that was encoded by the expression vector. The full-length original gene sequence is provided in 
appendix E2. The subcloning in the pASK-IBA 3C vector was verified by restriction digestion 
and gel electrophoresis at GenScript. The full-length, original gene sequence is provided in 
Appendix E2. This expression vector carries an anhydrotetracycline inducible promoter and has 
chloramphenicol resistance. 
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4.2.2 Preparation of competent S. blattae cells 
S. blattae strain DSM 4481
T
 was purchased from the Deutsche Sammlung von 
Mikroorganismen un Zallkulturen GmbH (Braunschweig, Germany) in frozen form. Frozen S. 
blattae cells were reconstituted by adding liquid Nutrient broth (Difco) and 10% glycerol stocks 
of S. blattae DSM 4481
T
 cells were prepared immediately for long term storage at -80 ºC. For 
culture maintenance, S. blattae DSM 4481
T
 was cultivated aerobically on LB agar plates [(LB 
Broth Lennox (Sigma) supplemented with 20 g/L agar (Difco)] at 37°C.  
For preparation of competent S. blattae cells, a single colony of S. blattae cells from an 
LB agar plate was innoculated into 10 mL of LB and grown overnight at 37°C. Then, 1.0 liter of 
LB was innoculated with 1% (v/v) overnight culture and grown until A600 = 0.5 to 1.0. The cells 
were subsequently chilled on ice for 15-30 minutes and centrifuged at 4.000×g for 15 min. 
Following centrifugation, supernatant was discarded, and the pellet was resuspended in 1 liter ice 
cold sterile water. That was followed by two more rounds of centrifugation at 4.000×g for 15 
min and washing the pellets in ice cold water. The cells were then resuspended in 20 mL ice cold 
sterile 10% glycerol prepared in deionized water and centrifuged at 4.000×g for 15 min. The 
pellets were then resuspended in 2-3 mL of 10% glycerol, and 40 µL aliquots of the cells were 
flash frozen using liquid nitrogen and stored at -80 °C until use in cloning. 
4.2.3 Transformation of the expression vector into host cells  
40 µL of competent S. blattae cells prepared as described above were mixed with 8 ng of 
recombinant plasmid DNA (pASK-IBA 37 plus/Dehly_1524) and then transferred to the bottom 
of a cuvette that was pre-chilled at -20 °C. The mixture was subjected to electroporation (Biorad 
electroporator) and immediately 1 mL of SOC was added. The SOC media was used from 
BL21(DE3)pLysS singles kit (Novagen Cat. No.70232-3). The mixture of cells was grown for 
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one hour at 37 °C, and then 50 µL aliquots were plated on LB agar plates supplemented with 50 
µg/mL ampicillin. The plates were incubated overnight aerobically at a temperature of 37°C 
before visual inspection to detect the appearance of colonies. 
When transformation with two plasmids was attempted, the two plasmids were mixed 
and 8 ng mixture of recombinant plasmids (pASK-IBA 37 plus/Dehly_1524) and (pASK-IBA-
3C/PceT) was added to 40 µL of competent S. blattae cells. The mixture was subjected to 
electroporation and after adding SOC media, cells were grown for one hour at 37 °C. 
Transformed cells were selected on LB agar plates supplemented with 50 µg/mL ampicillin and 
34 µg/mL chloramphenicol. 
4.2.4 Induction and overexpression of the Dehly_1524 protein under anoxic conditions 
For expression of the recombinant reductive dehalogenase protein in transformed S. 
blattae, cells were grown in a mineral medium containing (per liter): K2HPO4, (14 g) KH2PO4, (6 
g) (NH4)2SO4, (3 g) MgSO4·7H20 (0.02 g), CoCl2·6H2O (0.024 g), yeast extract (2 g), cysteine-
HCl (0.2 g), trace element solution 1 mL (see Appendix E2 for composition) and glycerol (300 
mM final concentration) (ph 7.5) as growth substrate along with 100 µg/mL ampicillin. Glycerol 
served as the carbon and energy source for the cells for cobamide production. External cobamide 
sources such as 5,6-dimethylbenzimidazole (DMB) (Sigma Cat. No. D147206-25G) and 
hydroxocobalmin (Sigma Cat. No. 95200-250mg) were added to the growth medium. Recent 
data has shown that the addition of these two external sources has a positive effect on the 
reductive dehalogenase activity of the protein (Mac Nelly et al., 2014). The final concentrations 
of dimethylbenzimidazole (DMB) and hydroxocobalmin were 10 µM and 10 nM, respectively. 
For the expression of the reductive dehalogenase protein, S. blattae cells harboring the 
recombinant plasmid pASK-IBA 37 plus/Dehly_1524 were grown in LB broth for 6 to 8 hours at 
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28 °C. This culture was used to innoculate 250 mL of anaerobic mineral medium contained in 
400 mL glass serum bottles. After dispensing the media in the bottles, the bottles were sealed 
using butyl rubber septa and aluminium crimp caps. The headspace was changed by flushing 
with filter sterilized Nitrogen gas. After flushing the headspace with nitrogen, the bottles were 
autoclaved, and filter sterilized ampicillin 100 µg/mL and vitamins dimethylbenzimidazole 
(DMB) and hydroxocobalmin were 10 µM and 10 nM, were added before inoculating with the 
transformed cells. When the PceT co expression was attempted, 34 µg/mL of chloramphenicol 
was also added in the anaerobic mineral medium. This anaerobic culture was grown at 18 °C 
with shaking at 100 rpm. After 6 hours when the OD reached 0.2-0.3, the cells were induced for 
protein expression by the addition of anhydrotetracycline (20 ng/mL final concentration). After 
7-8 hours of induction, the cells were collected by centrifugation 5,900×g for 10 minutes at 4 °C 
and then transfered into the anaerobic chamber. The cells were resuspended in anoxic buffer (10 
mM Tris-HCl made anoxic by flushing with filter sterilized N2 gas), and cell lysis was 
accomplished by detergent lysis using glass beads and digitonin (detergent). As an alternative 
method, the cells were also lysed using BugBuster protein extraction reagent (Novagen) with cell 
lysate prepared following the protocol provided by Novagen. The BugBuster protein extraction 
reagent was made anaerobic by flushing with filter sterilized Nitrogen gas and the addition of 
titanium citrate [0.5 mL of prepared titanium citrate (details provided in Section 3.2.2) per 10 mL 
of BugBuster reagent]. The cell extracts were then used for the dehalogenase assay developed 
previously using 400 mL culture of wild type D. lykanthroporepellens BL-DC-9
T
 cells. 
Uninduced S. blattae cells were used as a negative control in the enzyme assay. D. 
lykanthroporepellens BL-DC-9
T
 cells grown with 0.5 mM 1,2-DCP as the electron acceptor were 
used as positive control in the enzyme assay.  
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4.2.5 Detection of the expressed dehalogenase enzyme  
After 7-8 hours of induction, 500 µL of cell culture was extracted from the serum bottle 
using a syringe and cells were lysed using the BugBuster protein extraction reagent. A fraction of 
the suluble and insoluble fraction of the cell lysate were analyzed by 12% SDS-PAGE to check 
for the presence of the induced protein in the induced and uninduced cell culture. 
4.2.6 Experiments attempted to express the protein in the soluble fraction 
As described in the Results section of this chapter, the protein expressed by transformed 
S. blattae cells under the conditions described above in Section 4.2.4 was not observed to have 
catalytic activity under the conditions tested, and it was found to be associated with the insoluble 
fraction of cell lysates. In an attempt to obtain the protein in a soluble and catalytically active 
form, experiments were performed using a variety of alternate induction conditions. Induction 
was carried out at lower anhydrotetracycline concentrations and at shorter induction times. Two 
different culture volumes of 250 mL were innoculated with a single clone of transformed cells, 
and when the OD reached 0.25, induction was carried out at the final anhydrotetracycline 
concentrations of 10 ng/mL and 20 ng/mL. As a control, 250 mL of uninduced cell culture were 
also grown. 500 µL of induced cells were collected using a syringe at time intervals of 3, 5, and 
7 hours, and then analyzed for expression of the protein in the soluble fraction by running SDS-
PAGE. 
4.2.7 Experiments to address potential reductive dehalogenase ligand binding issues 
As described in the Results section of this chapter, the protein expression described above 
in Section 4.2.6 and 4.2.4 was not observed to have catalytic activity under the conditions tested. 
In an attempt to obtain the protein in catalytically active form, experiments were performed to 
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address the potential reductive dehalogenase ligand binding issue by mixing the cell lysates of 
the induced S. blattae cells and D. lykanthroporepellens BL-DC-9
T
 cells.  
400 mL of D. lykanthroporepellens BL-DC-9
T
 cells actively dechlorinating 1,2-DCP 
were collected by centrifugation at 5,900×g at 4 °C for 30 minutes. The centrifugation was done 
in batches of 50 mL cell culture in plug sealed 50 mL centrifugation tube (Corning). The 
supernatant was discarded using a 25 mL pipette leaving about 1 mL of culture in the 
centrifugation vial inside the anaerobic chamber. Approximately 8 mL of culture was collected 
after the first centrifugation step and the culture was centrifuged again at 5,900×g at 4 °C to 
obtain the cell pellet. The cell pellets were resuspended in 250 µL of 4× Sample prep Buffer 
(Native Gel Sample Prep Kit, Invitrogen, Cat. No. BN2008) containing 1% digitonin for 
detergent cell lysis. The resuspended cells were lysed by mechanical sheering in a horizontal 
shaker. The cell lysis was accomplished by two minutes of shaking followed by one minute of 
incubation on ice. At the same time, 250 mL of induced cell culture of transformed S. blattae 
cells were collected by centrifugation without exposing the cells to oxygen and cell pellets were 
resuspended in 5 mL of BugBuster reagent (Novagen) inside the anaerobic chamber. The 
resuspended cells were incubated on a rotating shaker at a slow setting for 10-20 minutes at room 
temperature. The cell lysates of D. lykanthroporepellens BL-DC-9
T
 and the transformed S. 
blattae cells cells were mixed in the ratio 1:1, and 50 µL of the mixture was used for the 
dehalogenase enzyme assay. As a positive control, 50 µL aliquots of crude cell lysate of D. 
lykanthroporepellens BL-DC-9
T
 cells were also used in the dehalogenase enzyme assay.  
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4.3 Results 
4.3.1 Transformation results 
The LB agar plates having 50 µg/mL ampicillin were incubated overnight for the 
appearance of the transformed colonies. Transformed S. blattae cells with only the pASK-IBA 
37 plus/Dehly_1524 (ampicillin resistant) were observed the following day on the selection 
plates.  
4.3.2 Expression of the 1,2-DCP reductive dehalogenase protein from strain BL-DC-9
T
 in S. 
blattae 
To check for the expression of the induced 1,2-DCP protein in transformed S. blattae 
cells containing pASK-IBA 37 plus/Dehly_1524, a fraction of the induced and uninduced cell 
culture was analyzed by 12% SDS-PAGE as described previously in Section 3.2.5.1. The 
expected sized protein fragment of 53 kDa was detected consistently predominently in the 
insoluble fraction of the induced cultures (Figure 4.2). The expression of the protein was 
consistently observed after induction for 8 hours at 18 °C at a final anhydrotetracycline 
concentration of 20 ng/µL. 
Recombinant S. blattae cells that were selected with two antibiotics were also induced by 
anhydrotetracycline (final concentration 20 ng/mL) and induced for 8 hours at 18 °C. However 
the PceT co-expression was not seen when cell lysates were analyzed by 12% SDS-PAGE (see 
Appendix E1). 
Regardless of induction conditions, the protein was consistently detected mostly in the 
insoluble fraction. Expression of the protein was detected in the insoluble fraction when the 
expression was attempted at lower anhydrotetracycline concentration of 10 ng/µL and after 
induction for 3, 5, and 7 hours respectively (see Figure E2 in Appendix E).  
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Figure 4.1 SDS-PAGE analysis of the cell lysate and soluble fraction from transformed S. blattae 
containing the recombinant plasmid with Dehly_1524 grown at 18 ºC. Expected sized (53 kDa) 
protein band observed with cell lysate (lane 3). Lane 2 is the uninduced transformed S. blattae 
cells whereas Lane 1 is the soluble fraction. 
4.3.3 Enzyme assay results from the induced proteins 
No enzyme activity was observed from the large scale protein induction (using 250-1000 
mL of cell culture volume) using the transformed S. blattae cells. Induced protein (crude lysate) 
in the concentration range of 250-750 µg was used for the dehalogenase enzyme assay; however, 
using this range of protein did not show functional activity. For every assay performed, a fraction 
of the induced cell culture was analyzed by 12% SDS-PAGE. The expected sized protein was 
consistently observed in the SDS PAGE analysis in the insoluble fraction. 10-15% 
10 kDa 
250 kDa 
    1                         2                  3                 M  
53 kDa 
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dechlorination was consistently observed in positive controls with cell lysates from D. 
lykanthroporepellens BL-DC-9
T
.  
The Mac Nelly et al., group also used a range of 250-750 µg of protein in the 
dehalogenase assay. Dehalogenase activity was detected when this range of protein was tested in 
the enzyme assay. Recently a functional dehalogenase was expressed using E. coli as the host. 
The purified and cofactor reconstituted vinyl chloride reductive dehalogenase at a concentration 
0.2-1.0 mg/mL was shown to exhibit dehalogenase activity (Parthasarathy et al., 2015).  
4.3.4 Enzyme assay results from the ligand binding experiments 
For the enzyme assays using mixtures of induced lysates of transformed S. blattae and D. 
lykanthroporepellens BL-DC-9
T
, approximately less than 50% enzyme activity was observed in 
the dehalogenase enzyme assay when the lysates of S. blattae and D. lykanthroporepellens BL-
DC-9
T
 were mixed in the ratio 1:1 in comparison to the positive controls using only BL-DC-9
T
 
cell lysate. 
4.4 Discussion 
Because the first functional expression of a reductive dehalogenase was reported in the 
cobamide producing S. blattae, it was speculated that it may work in the functional expression 
Dehly_1524. The tetrachloethene reductive dehalogenase (PceA) of the Desulfitobacterium 
hafniense strain Y51 and rdhA3 of D. hafniense DCB-2 was functionally expressed in the S. 
blattae cells (Mac Nelly et al., 2014). Hence, functional expression of the 1,2-DCP reductive 
dehalogenase protein from strain BL-DC-9
T
 was attempted using S. blattae as the host. The gene 
was synthesized along with the TAT signal sequence because when the first functional 
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expression of a dehalogenase was successfully carried out, it included the full-length reductive 
dehalogenase gene (Mac Nelly et al., 2014).  
The 53 kDa 1,2-DCP reductive dehalogenase protein (Dehly_1524) was found to be 
expressed consistently in S. blattae cells under anoxic conditions in the insoluble fraction. The 
(PceA) of the D. hafniense strain Y51 was also found to be expressed in the insoluble fraction in 
the same S. blattae host, and functional activity of this enzyme was reported in spite of the 
protein being expressed in the insoluble fraction (Mac Nelly et al., 2014). Co-expression of the 
PceT gene reportedly increased the solubility and functional activity of this enzyme (Mac Nelly 
et al., 2014). In all attempts that were made to express the Dehly_1524 protein in experiments 
reported here, the protein was expressed in the insoluble fraction and it was found to be 
enzymatically inactive in spite of using a range of induction times and a range of 
anhydrotetracycline concentrations for induction.  
The insert gene PceT was sequenced at GenScript (Piscataway, NJ) after the subcloning 
in the pASK-IBA 3C vector and the sequencing results were consistent with the targeted gene 
sequence. However, attempts to co-express the PceT gene from D. hafniense along with the dcpA 
gene from D. lykanthroporepellens in the S. blattae cells were not successful. It remains a 
possibility that although the DcpA protein was being made in the S. blattae cells, the protein was 
nonfunctional because the oxidation reduction potentional was outside the limit for the functional 
activity of the enzyme. Also, it may be that 5,6-dimethylbenzimidazole (DMB) and 
hydroxocobalamine are not the cofactors required for the functional activity of the enzyme. 
Alternatively, it is also possible that the de novo cobamides synthesized in the S. blattae cells do 
not function as cofactors, and hence, it fails to produce the mature form of the enzyme.  As 
mentioned in the previous chapter, cobamide extraction and analysis has shown that the S. 
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blattae cells could produce pseudo-B12 that has dimethylbenzimidazole or adeninyl as the lower 
ligand. The dimethylbenzimidazole or the adeninyl moiety may not be the required cofactor for 
the DcpA enzyme. It remains likely that the de novo cobamides synthesized in the S. blattae cells 
do not function as cofactors, and hence, fail to produce the mature form of the enzyme. The 
cobamide cofactor that may actually be needed for the functional activity of the DcpA protein 
still remains unknown and is possibly not produced endogenously by the S. blattae cells and was 
not added to the cell culture. 
Refolding of the vinyl chloride reductive dehalogenase protein from the insoluble 
fraction followed by iron sulfur cofactor reconstitution in the presence of hydroxocobalamin has 
shown functional activity (Parthasarathy et al., 2015). It remains to be investigated if the iron 
sulfur cofactors were reconstituted into the DcpA protein during expression in S. blattae cells. 
The possibility that the iron sulfur cluster was not incorported into the enzyme cannot be ruled 
out. The reconstituted iron sulfur cluster could possibly mediate an electron transfer, which could 
possibly be a critical step during the dehaloelimination process. Hence failure to reconstitute the 
iron and sulfur cofactors in the DcpA protein during expression in S. blattae could be a plausable 
reason for the expression of a catalytically inactive enzyme. 
In previous attempts to express a functional dehalogenase in E. coli, the absence of a de 
novo cobamide biosynthesis pathway was speculated to be a likely reason for the failure to 
produce a functional protein. Work reported herein, however, indicates that presence of a de 
novo pathway is not sufficient for the functional expression of this family of proteins. In an 
attempt to resolve this potential issue, experiments were carried out to test if mixing the cell 
lysates of D. lykanthroporepellens BL-DC-9
T
 and S. blattae cells could produce a functional 
enzyme. The cell lysates of S. blattae and D. lykanthroporepellens BL-DC-9
T
 were mixed in the 
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ratio 1:1 and used in the dehalogenase enzyme assay and the enzyme activity was compared to 
the postive controls using only BL-DC-9
T
 cell lysate. Dehalogenase enzyme activity in the 
mixture of induced S. blattae and D. lykanthroporepellens BL-DC-9
T
, however, was 
approximately 50% lower than the positive controls containing cell lysates of only D. 
lykanthroporepellens BL-DC-9
T
, indicating that mixing the S. blattae and D. 
lykanthroporepellens BL-DC-9
T 
did not resolve the ligand binding issue. Functional 
dehalogenase activity was recently observed by Parthasarathy et al., 2015 using a very high 
concentration of purified and cofactor reconstituted vinyl chloride reductase (0.2-1.0 mg/ml). 
However the concentration of protein in the cell lysates of S. blattae was less than than the 
concentration of purified enzyme that exhibited functional activity. Hence it remains a possibility 
that catalytically active enzyme was produced but the amount of protein used in the assay was 
not adequate to show a dehalogenase activity.  
Hence it can be concluded from these experiments that while S. blattae can be used for 
the functional expression of some reductive dehalogenase proteins (i.e., those from D. hafniense 
as reported by Mac Nelly et al., 2014), it may not work for all proteins of this family. 
4.5 Conclusions 
Since functional expression of the 1,2-DCP reductive dehalogenase protein was not 
possible in E. coli, with absence of the cobamide cofactor most likely a contributing factor, 
functional expression of the protein was attempted in the cobamide producing S. blattae cells. 
The protein was expressed in the insoluble fraction, and functionally active protein was not 
obtained. Also, mixing the S. blattae and D. lykanthroporepellens BL-DC-9
T
 cell lysates did not 
produce a catalytically active enzyme. Hence, it can be concluded that although S. blattae has 
been successfully used as a host for functional expression of (PceA) of the D. hafniense strain 
 75 
 
Y51 (Mac Nelly et al., 2014) this species should not be assumed to be a universal host for 
expression of other dehalogenase proteins. Heterologous expression of functional reductive 
dehalogenases remains a challenge. 
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Chapter 5. Overall conclusions and recommendations for future research 
 
5.1 Overall conclusions 
 
Transcriptomic studies were performed to study the pattern of gene expression in 
Dehalogenimonas lykanthroporepellens BL-DC-9
T
 during organohalide respiration in presence 
of 1,2-DCA, 1,2-DCP and 1,2,3-TCP as electron acceptors. Using the genome sequence 
available for this strain, specific primer pairs were designed targetting all 25 rdhA gene 
sequences present in BL-DC-9
T
. For six of the rdhA genes having the cognate rdhB genes, 
primers were designed that spanned both genes, and this was used to check if the two genes were 
cotranscribed. RNA extracted from actively dechlorinating cultures of BL-DC-9
T
 was reverse 
transcribed, and expression of the rdhA and rdhAB genes was detected by polymerase chain 
reaction in conjunction with designed primers. From this study, it was observed that the pattern 
of gene expression in D. lykanthroporepellens BL-DC-9
T
 was identical during organohalide 
respiration with all three electron acceptors that were used in this study (i.e., 1,2-DCA, 1,2-DCP, 
and 1,2,3-TCP). Transcripts from nineteen rdhA genes were consistently detected from the RT-
PCR experiments irrespective of the electron acceptor used. This included thirteen full-length 
rdhA genes, 6 truncated rdhA genes, and 5 rdhA genes having the cognate rdhB gene. The five 
rdhB genes were also found to be co-expressed with their corresponding rdhA genes. The six 
rdhA genes for which transcripts were not detected in any of the RT-PCR experiment appear 
unlikely to play a role in the organohalide respiration process using the substrates tested here.  
The three transcripts lacking the TAT signal sequences and detected in the gene 
expression study Dehly_0069, Dehly_1523 and Dehly_1582 are interesting candidates for 
functional heterologous productions. They appear to be expressed under all the tested conditions 
and they lack the TAT signal sequence and the membrane anchoring rdhB gene indicating they 
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are not membrane proteins. Hence they can possibly be expressed in the soluble fraction both in 
E. coli and S. blattae. The six transcripts that were not detected in the gene expression study 
included 4 full-length rdhA genes (Dehly_0068, Dehly_0283, Dehly_1355 and Dehly_1540) and 
two truncated rdhA genes (Dehly_0075 and Dehly_1533/Dehly_1534). Both Dehly_0075 and 
Dehly_1533/1534 lack the TAT signal sequence and hence both possibly code for truncated 
cytoplasmic proteins having no role in the organohalide respiration process. That some full-
length rdhA genes were not transcribed likely reflects that they are under control of transcription 
factors that respond to ligands other than the compounds used in this study. 
Transcripts from the four regulatory genes that are associated with the rdhA genes were 
detected in this study, indicating their involvement in regulation of gene expression during the 
biotransformation process. The majority of the rdhA genes in Dehalococcoides mccartyi are 
associated with either two component system (TCS) regulators or MarR regulators (Kube et al., 
2005; Seshadri et al., 2005). However, the genome analysis shows the presence of only four 
regulatory genes adjacent to the rdhA genes in D. lykanthroporepellens BL-DC-9
T
. The 
regulatory genes may possibly regulate other rdhA genes and not only the adjacent rdhA genes. 
Hence, it can be inferred that the two component systems transcription regulator Dehly_1149 
located adjacent to the rdhA Dehly_1148 may be involved in regulation of other rdhA genes such 
as Dehly_1152 and not only the adjacent rdhA genes.  The regulation of the rdhA genes is not 
compound specific and rather promiscuous, an observation that must derive from the ligand-
specificity of associated regulators. The genome sequence shows the presence of a MarR 
orthologue Dehly_0120 located immediately upstream and in opposite orientation of RdhA 
Dehly_0121. A pseudo-palindromic sequence (TCGATGTAATATTACATGTA) with two half 
sites for MarR binding were found to be located immediately upstream of the Dehly_0121 gene, 
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strongly suggesting that this site serves as the MarR binding site. The genome sequence of BL-
DC-9 was analyzed using pattern locator software (Mrazek and Xie, 2006) for MarR binding site 
and the analysis showed that similar palindromic sequences were not present upstream of any of 
the other rdhA genes. Hence it is concluded that the MarR orthologue likely regulates the 
expression of Dehly_0121 and not other rdhA genes.  
The remaining transcription factors that are encoded adjacent to rdhA genes are part of 
two-component systems. Sensor kinases would be expected to respond to specific signals (the 
presence of halogenated compounds) by transferring a phosphoryl group to the response 
regulator, which in turn controls gene expression. These response regulators also belong to the 
helix-turn-helix family of DNA binding proteins and would be expected to recognize 
palindromic sequences. Searching the genome with the palindromic sequence 
TACAATTATTGTA found in the Dehly_1152 (rdhA) promoter uncovered similar sites in the 
Dehly_1148 and Dehly_0156 promoters. This raises the possibility that these three genes are 
controlled by the same regulator, perhaps the two-component regulator encoded by Dehly_1149-
1150. 
Although it was not possible to uniquely identify the enzyme-coding genes from this 
study, this study does provide insights into the gene expression pattern during the dechlorination 
process in this interesting organism. The primers developed in this study can be used in future 
studies for quantifying the transcripts using a qRT-PCR approach. Also the primers can be used 
as probes for checking the presence of these genes from environmental samples and have 
potential utility in assessing rdh gene expression at contaminated sites.  
Once the pattern of gene expression was identified, the next study was done to 
heterologously express a catalytically active dehalogenase enzyme. One of the rdhA genes whose 
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transcripts were detected consistently during the dechlorination of 1,2-DCA, 1,2-DCP and 1,2,3-
TCP has been characterized as the gene responsible for the biotransformation if 1,2-DCP. This 
gene, with the locus tag Dehly_1524, was chemically synthesized and codon optimized for 
expression in E. coli. It was subcloned in pET-16b and transformed into E. coli 
BL21(DE3)pLysS cells for expression. In spite of many attempts, however, the protein was 
found to be functionally inactive and the majority of the protein was expressed in the insoluble 
fraction. Refolding the protein from the insoluble fraction in the presence of the vitamin B12 did 
not produce a functional protein. The inability to achieve functional expression of the protein in 
E. coli is likely due to the absence of a de novo cobamide biosynthesis pathway in the E. coli 
cells. 
Because the first successful expression of a reductive dehalogenase protein was reported 
using S. blattae and since E. coli was found to be unsuitable due to the absence of a cobamide 
biosynthetic pathway, expression was tried using S. blattae as an alternate host (Mac Nelly et al., 
2014). The presence of a de novo cobamide biosynthesis pathway in S. blattae makes it a 
promising host for testing the functional expression of dehalogenases. Using the same approach 
by the Mac Nelly et al. (2014) group, the Dehly_1524 protein was expressed under anoxic 
conditions in S. blattae cells. The functional protein could not be obtained, however, and despite 
all attempts, the protein was mostly expressed in the insoluble fraction. Attempts to co-express 
the PceT protein along with the Dehly_1524 protein were not successful with S. blattae cells. 
This indicates that S. blattae may not function as a genetic host for the expression of all 
dehalogenase enzymes, particularly those from the genus Dehalogenimonas. It could be that the 
cobamides produced by S. blattae differ in the lower axial ligand from the cobamides used by D. 
lykanthroporepellens BL-DC-9
T
, resulting in a catalytically inactive enzyme. Since a mixture of 
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S. blattae and D. lykanthroporepellens lysates did not result in restoration of functional activity, 
it is also likely that the cobamide cofactor must be present during protein folding. 
5.2 Recommendations for future research 
To obtain further insights into the rdhA gene expression, the transcript levels of the 
nineteen detected rdhA genes could be quantified using quantitative RT-PCR or using 
microarrays. Because the heterologous expression of a functional dehalogenase was not 
successful in the experiments described here, a wide scope exists for method development for 
successfully producing functional dehalogenases from D. lykanthroporepellens BL-DC-9
T
. 
Attempts to try different cobamides as cofactors represents one option, and trying to express the 
protein in an even more reducing environment remains another possibility. It remains to be 
investigated whether reconstituting the Fe/S clusters in the expressed proteins might result in the 
production of functionally active proteins. Once a method is developed for functional expression 
of reductive dehalogenases, the enzyme’s substrate specificity can be studied by testing 
dechlorination activity on different halogenated electron acceptors. Enzyme kinetics of a 
functional enzyme would obviously be worth study, and additional experiments are needed for 
the purification of the protein. Determining the X-ray structure of the protein for prediction of 
the active sites of the protein would be a logical step. 
Additional research is required for characterization of several other rdhA genes that were 
detected in the RT-PCR experiments. In total, five rdhA-rdhB operons were detected in the gene 
expression study. It is needed to check if the other rdhA genes such as Dehly_0156, Dehly_0275, 
Dehly_1152 and Dehly_1054 can be functionally expressed heterologously. It may be possible 
that the other detected dehalogenase genes are actually enzyme coding genes catalyzing the 
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transformation of 1,2-DCA or 1,2,3-TCP. Functional expression of the other dehalogenase genes 
could provide further insights into the dechlorination process in this organism. 
As a means of providing a potential roadmap for future efforts to overcome protein 
misfolding in hetologous expression of reductive dehalogenases, the following sub-sections 
review some alternative approaches that may prove successful in resolving DcpA protein 
aggregation. 
5.3 A review of different approaches that can be potentially be used to resolve the DcpA 
protein aggregation 
Protein misfolding or aggregation is one of the most commonly observed obstacles in 
structural genomics and proteomics research (Yokoyama, 2003). Many interesting families of 
proteins such as membrane proteins, kinases and phosphatases are extremely onerous in getting 
expressed in the soluble fraction of E. coli cells (Esponsito and Chatterjee 2006). To obtain such 
recombinant proteins in their soluble (i.e., non-aggregated) form, a wide variety of techniques 
have been employed.  As described in the following sub-sections, these approaches can be 
broadly categorized as (1) changing the growth conditions of the transformed cells and altering 
the rate of protein synthesis, (2) changing the expression host, (3) use of solubility fusion tags. In 
addition statistical methodologies to prevent protein aggregation and some experimental 
approaches for protein refolding from the insoluble fraction are mentioned in section 5.3.4 and 
5.3.5. 
5.3.1 Changing the growth conditions of the transformed cells and altering rate of protein 
synthesis 
One of the primary factors that can improve the solubility of recalcitrant proteins is by 
altering the media or culture composition. The concentration of peptone and yeast extract in the 
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protein induction media are known to have an affect on the protein solubility (Larentis et al., 
2011). Several compounds are reported that when added to the culture medium result in proper 
protein folding and increase the solubility. These include sorbitols, thiols, ethanol and disulfides 
(Georgiou et al., 1996, Chopra et al., 1994).  
The next factor that often inhibits protein aggregation in expression hosts is altering the 
rate of protein synthesis in the expression hosts. Induction of the protein expression in the late 
log phase and in some instances in the stationary phases have led to the production of the protein 
in the soluble fraction (Galloway et al., 2003, Ou et al., 2004). Mammilian RNA binding protein 
has been successfully expressed in high quantity in the soluble fraction in E. coli cells by using 
lower concentration of IPTG at the late log phase (Galloway et al., 2003). The induction 
temperature and the length of the induction time can affect both the protein expression and the 
protein solubility (Papaneophytou and kontopidis, 2014). Induction of the proteins at 
temperatures below the optimal temperatures for cell growth has been reported for expression of 
soluble proteins in bacterial hosts as lower temperatures slow down the cell growth and protein 
expression (Schein et al., 1988). At this point, the optimum temperature and the length of the 
induction time for a particular protein can only be determined by trial and error. 
 Expression of the target proteins without using an external inducing agent can also be a 
favourable option for the expression of tricky proteins in the soluble fraction. In this approach, 
generally an autoinduction media is used to express target proteins placed under the control of a 
lacUV promoter and this system was used for the expression of selenomethionine 
labeled fusion proteins in E. coli cells (Sreenath et al., 2005). Both glucose and lactose are 
supplemented to the autoinduction media, and leaky expression of the target protein is prevented 
by catabolite repression. When glucose from the autoinduction media is used up, the lactose 
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metabolite allolactose is produced that acts as the inducer for the lacUV promoter and leads to 
the expression of target proteins (Sreenath et al., 2005).  
The pET16b vector was used for the expression of the DcpA protein in this study. The 
pET16b uses an IPTG-inducible, bacteriophage T7 promoter that has been widely used for 
expression of a large number of proteins effectively (Tabor et al., 1985). It was observed, 
however, that the majority of the DcpA protein was expressed as inclusion bodies. Hence, this 
expression may not be suited for preventing protein aggregation of the DcpA protein. Other than 
the above mentioned T7 expression system, cloning and expression using the tightly controlled 
araC promoter (Guzman et al., 1995) that is inducible by arabinose remains a favorable option 
for producing protein in the soluble fraction. A switch to a weaker expression system, such as a 
lac promoter may lead to the slower expression of the desired protein and hence may be useful 
for rectifying the protein aggregation that results from faster protein expression (Labendiker and 
Danieli, 2014).  
Slower expression of proteins using a cold shock promoter like cspA has also been 
reported to solve the protein aggregation problem (Vasina et al., 1996). Using lower 
temperatures for the expression of difficult proteins have often circumvented the inclusion body 
formation problem (Schein, 1989). Still a significant percentage of proteins are expressed as 
inclusion bodies when expressed at sub-optimum temperatures (15-30 ºC) in E. coli systems 
(Song et al., 2012).  
A number of protein solubilizing agents, osmolytes and key additives have been 
characterized as agents that increase solubility of misfolded proteins (Bondos et al., 2003, Leibly 
et al., 2012, Jain and Roy, 2009). Some of the media additives such as CTAB, K2PO4, proline, 
glycine, potassium citrate, xylitol, CuCl2 are among the important protein solubilization agents 
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(Leibly et al., 2012). L-arginine has been widely used as a protein solubilization additive since it 
has been reported to subdue protein aggregation (Arakawa et al., 2007). 
5.3.2 Changing the expression host 
Another factor that can affect the solubility of the recombinant protein in the choice of 
the expression host. The E .coli BL21(DE3) system is usually the standard genetic host system 
for the production of recombinant proteins (Shaw et al., 1967). Membrane-bound proteins that 
are difficult to express in the soluble fraction of BL21(DE3) cells have been expressed without 
inclusion body formation in mutant E. coli strains C41(DE3) and C43(DE3) (Miroux et al., 
1996). Preference of using these mutant cells as the expression host over the standard BL21 cells 
can be a promising choice for expression of the membrane-bound proteins. The recently 
genetically engineered E. coli mutant Lemo 21(DE3) strain has also been reported as a preferable 
choice for membrane protein solubilization (Hjelm et al., 2013). The Ralstonia eutropha 
expression system has been reported as a higher ranking expression system in comparison to the 
standard E. coli system as an expression in this system minimizes inclusion body formation 
(Barnard et al., 2004). Several strains of the genus Bacillus have been reported to act as better 
host for the expression of recombinant proteins (Demain and Vaishnav, 2008). Bacillus 
megaterium, B. subtilis and B. licheniformis are some of the species of the genus Bacillus that 
are routinely used for heterologous protein expression (Demain and Vaishnav, 2008). Hence, it 
can be concluded that apart from the standard E. coli system other bacterial expression systems 
may be used for expression of recombinant proteins that are found to be misfolded in the E. coli 
system. 
Use of extremophilic E. coli strain such as E. coli ArcticExpres as expression hosts has 
resulted in successful expression of soluble proteins at temperatures below 10 ºC (Ferrer et al., 
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2003). Protein aggregation and misfolding was prevented when the expression host E. coli 
Rosettagami2 (DE3) was grown at a temperature below 10 ºC (Song et al., 2012). This specific 
study exhibited that protein misfolding for difficult proteins such as Cryptopygus antarticus 
mannase can be prevented using low induction temperatures (6-10 ºC). This recent study is a 
significant refinement of the study of recombinant proteins that are expressed as aggregates at 
optimal temperatures for E. coli growth. Hence using E. coli Rosettagami2 (DE3) strains for the 
expression of the DcpA protein at a sub-optimal temperature of (6-10 ºC) seems to be a plausible 
option to express the protein in the soluble fraction. 
5.3.3 Use of solubility fusion tags 
One of the key factors that have lead to a significant improvement if the field of protein 
expression and solubilization is the development and use of solubility tags to reduce protein 
aggregation. GST (Glutathione S-transferases) and maltose binding affinity tags are the most 
frequently used tags for solubility enhancement of proteins that have low solubility and tend to 
form inclusion bodies (Yokoyama 2003, Smith et al., 1988). The GST/Bombyx mori 
nucleopolyhederovirus DNA polymerase fusion protein has resulted in higher quality of 
heterologous expression of this protein in E. coli. The GST/Bombyx mori nucleopolyhederovirus 
DNA polymerase fusion protein was further purified using affinity chromatography (Song et al., 
2014). Similarly elastin like polypeptides that were mostly expressed as aggregates when 
expressed in E. coli cells were found to be expressed in the soluble fraction when fused to the 
maltose binding protein (Batallie et al., 2015). The use of the GST tag however often leads to the 
expression of truncated proteins and thereby fails to resolve the protein aggregation completely 
(Labendiker and Danieli, 2014). Maltose binding tags function not only in protein solubilization 
but also act as protein stabilizers (Labendiker and Danieli, 2014). However, a severe 
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disadvantage of this solubility tag is that it has a large size and hence its use is limited only to the 
solubilization of smaller proteins (Labendiker and Danieli, 2014). The E. coli expression system 
is ineffective at proper folding and solubilization of large sized fusion proteins (Labendiker and 
Danieli, 2014). Hence, larger sized proteins are generally misfolded when fused to a maltose 
binding tag and expressed in an E. coli system. The NusA (N utilization substance A) tag has 
also been reported to be an effective fusion protein that prevents protein aggregation. 
Catalytically active human interleukin was expressed as a fusion protein in the soluble fraction 
usig a fusion NusA tag and was purified using metal affinity chromatography (Davis et al., 
1999). The use of the NusA tag as a protein solubilizer in E. coli also suffers from a similar 
drawback like the maltose binding tags. In spite of having higher solubility than maltose binding 
tags, a large size of 55 kDa prevents its effective usage in the expression of larger proteins in 
bacterial systems (Nallamsetty and Waugh, 2006). The other major drawback of these solubility 
tags is that they are not suitable for the NMR spectroscopy of tagged proteins and cleaving out 
these tags before NMR spectroscopy often tends to decrease the protein solubility (Yokoyama, 
2003).  
A development in the field of NMR spectroscopy for proteins with low solubility has 
been the development of the non-cleavable N-terminal G fusion protein (B1 domain) (Zhou et 
al., 2001). This tag has been developed as a non-cleavable solubility tag that does not interfere 
with the functionality of the protein and is hence useful for determination of protein structure 
(Zhou et al., 2001). It has been reported that the GFP (Green fluorescent protein) can be used as 
the N-terminal fusion tag to rectify protein misfolding and enhance the solubility of proteins 
(Pedelacq et al., 2002). Using GFP as the N-terminal fusion tag led to the expression of a 
hyperthermophilic protein successfully in E. coli (Pedelacq et al., 2002). The fluorescence 
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signals from GFP-tagged proteins in the E. coli host cells is a signal to confirm the correct 
refolding of misfolded proteins and the GFP tag serves as the folding reporter (Waldo et al., 
1999). In many instances study of the interactions of low soluble proteins with other proteins, 
nucleic acids and ligands are critical for enhancing the solubility of the proteins. Co-expression 
of associated chaperones and refolding proteins can result in the expression of the protein in the 
soluble fraction. Co-expression of bacterial periplasmic chaperones such as thiol disulfide 
oxidoreductases and peptidyl-prolyl cis trans isomerases has been effective in production of 
soluble recombinant proteins in bacterial systems (Schlapschy et al., 2011). The first instance of 
heterologous production of a soluble reductive dehalogenase was the pceA gene from 
Dehalobacter restrictus (Sjuts et al., 2012). The soluble protein was expressed in an E. coli host 
system by fusing the PceA with a strep tag as a solubility tag (Trigger factor) and by expressing 
the protein at cold temperatures. The fusion protein was purified using a StrepTactin Sepharose 
resin. The tetrachloethene reductive dehalogenase (PceA) of the Desulfitobacterium hafniense 
strain Y51 was functionally expressed in the S. blattae cells. This specific study exhibited that 
the production of the soluble enzyme increased when the trigger factor chaperone PceT located 
downstream was co expressed along with the pceA gene (Mac Nelly et al., 2014). 
In addition to the above-mentioned affinity tags there are numerous other tags that have 
been successfully used for increasing the solubility of misfolded proteins. These include 
calmodulin binding peptide (Wyborski et al., 1999), and thioredoxin (trx) (LaVallie et al., 1993). 
Calmodulin binding proteins have binding affinities for calmodulin and can be purified using 
calmodulin affinity chromatography. Heterologous expression and purification of the c-Jun-N 
terminal kinase protein has been reported in E. coli using an N terminal calmodulin binding 
protein (Wyborski et al., 1999). The thioredoxin fusion tag has led to the functional production 
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of eukaryotic cytokines in the soluble fraction in E. coli cells (LaVallie et al., 1993).The 
solubility fusion tags are frequently used along with a simple histidine tag that functions as 
affinity tags to permit the purification of soluble proteins (Porath, 1992). Other frequently used 
N-terminal fusion tags for enhancing protein solubility includes fusion of the SUMO protein 
(Butt et al., 2005), HaloTag7 (Ohana et al., 2009) and ubiquitin (Catanzariti et al., 2004). N 
terminally fused SUMO (Small ubiquitin related modifier) tags have been used for the functional 
expression of green fluorescent proteins (Malakhov et al., 2004). The major edge of the SUMO 
tag is that it is easily cleavable from the fusion protein using SUMO proteases and has a higher 
efficiency for increasing solubility of larger proteins due to its small size (Labendiker and 
Danieli, 2014). The HaloTag7 that is derived from a nonfunctional haloalkane dehalogenase 
from Rhodococcus species (Janssen, 2004) is one of the most effective tag in protein 
solubilization. Experimental testing of the HaloTag7 as a fusion protein to 23 human proteins 
have produced soluble heterologous production of 74% of these proteins in E. coli (Ohana et al., 
2009). 
Inclusion body formation is also a major obstacle in the functional expression of 
eukaryotic proteins in E. coli (Chatterjee and Esponsito, 2006). Successful expression of human 
proteins such as IL 13 and folliculin in E. coli using tags derived from bacteriophage T7 protein 
kinase and small E. coli chaperone skp have been described (Chatterjee and Esponsito, 2006). 
The remarkable advantage of these two tags over other previously reported tags was that the 
expressed proteins remained in the soluble fraction even after removal of the tags through 
protease cleavage (Chatterjee and Esponsito, 2006). Hence, using bacteriophage T7 protein 
kinase and small E. coli chaperone skp as fusion tags while expression in E. coli remains an 
option for the expression of truculent proteins that otherwise tend to aggregate during expression.  
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In the absence of experimental testing, identification of a specific tag that may function 
as a solubilizer for an uncharacterized protein is difficult. Hence, tag switching is routinely 
performed in order to identify the tag(s) that may increase the protein solubility. In spite of the 
success of solubility tags for increasing protein solubility, major challenges remain with the use 
of solubility tags (Labendiker and Danieli, 2014).  These include the high costs associated with 
the removal of the solubility tags post protein expression and loss in protein solubility and 
functional activity post removal of the solubility tags (Labendiker and Danieli, 2014). 
It can be seen from this review that there are numerous modifications (e.g., changing 
media compositions, switching between solubility tags, using different promoters and different 
host system and induction for shorter durations and at lower temperatue) that could be made to 
the expression system to prevent potential protein misfolding. An approach that combines many 
of these modifications together has also been reported to result in enhanced protein solubility 
(Labendiker and Danieli, 2014). In this approach, a preliminary analysis of the target proteins are 
undertaken using bioinformatics tools to identify the protein characteristics (such as 
hydrophobic, membrane-bound, intrinsically disordered, associated with chaperones etc). The 
analyzed proteins are then fused to N-terminal solubility enhancement tags depending on the size 
of the protein (SUMO tags for larger sized proteins and maltose binding tags for smaller sized 
proteins). This approach tests at least four different E. coli host strains as the protein expression 
host. Apart from the regular BL21 (DE3) and HMA174 (DE3) hosts strain C41 (DE3) and C43 
(DE3) are all transformed with the solubility tag-target fusion construct. The transformed 
recombinant cells are subsequently innoculated in an autoinduction media for 16 hours and 
induced at different temperatures. After the induction, the induced cells are lysed and expression 
of the target proteins are verified by SDS-PAGE and Western blot analysis. After determination 
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of the best possible host-construct combinations, additional factors such as induction temperature 
and induction durations can be determined by trial and error. This strategy has proven effective 
to minimize protein aggregation for a lot of difficult proteins (Labendiker and Danieli, 2014). 
5.3.4 Statistical methodologies to prevent protein aggregation during heterologous 
expression 
Because trial-and-error testing to determine which combinations of many factors may 
prevent protein aggregation remains a very laborious job, different statistical approaches have 
been recently devised to provide guidance in combining different factors that affect protein 
solubility (Singh et al., 2009). Statistical design of the experiments uses factorial experimental 
models to reduce the total number of experiments (Chambers et al., 2009).  
An effective statistical approache to minimize protein aggregation is to use a full factorial 
design that uses all possible experimental factors affecting protein solubility. If k is the number 
of factors for a particular experiment and each factor has an upper and lower level, then 2
k
 is a 
possible 2-level full factorial design. Using this full factorial model, multiple simulation runs can 
be made for each of the factors, and results for the combined effect of all the factors can be 
obtained (Chambers et al., 2009). A partial factorial design is used in the case of a large number 
of experimental factors. A partial factorial design uses a large number of factors, however with 
reduced number of variables and only a fraction of the total experimental conditions are 
analyzed. The statistical approach of full and partial factorial design has been successfully used 
to identify several potential factors affecting protein solubility such as inducer concentrations, 
induction time, cell line and media and the effects of using protein solubilizers (Benoit et al., 
2007). As innumerable variable factors such as expression host, solubility fusion tag, induction 
temperatures, culture medium can have major and minor effects in protein aggregation. It is 
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actually almost impossible to identify the effects of each of the variables; hence, only the factors 
that have major effects should be taken into consideration. The total and partial factorial design 
approach helps in the identification of the major effects of the variable factors (Abergel et al., 
2003). The data collected from the total and partial factorial design approach can be analyzed 
using available statistical methods such as ANOVA (univariate analysis of variance), MANOVA 
(multivariant analysis of varient) and linear coefficient analysis (Papaneophytou and Kontopidis, 
2014). 
In addition to the factorial design models, increase in protein solubility has also been 
achieved using the response surface methodology (Tabandeh et al., 2008). Response surface 
methodology in combination with factorial design model was used for the expression of multiple 
eukaryotic proteins in bacterial expression systems (Papaneophytou et al., 2013, Papaneophytou 
et al., 2014). In these studies, a statistical analysis identified BL21 (DE3) pLysS as the most 
suitable expression host. Subsequently the optimum optical density for induction, inducer 
concentration, induction temperatures and duration of induction to minimize protein aggregation 
was achieved by response surface methodology. In a separate study, the effect of several factors 
on protein solubility of the recombinant zinc-metalloprotease was investigated using fractional 
factorial study in combination with response surface methodology (Beigi et al., 2012).The 
fractional factorial study was used to investigate the effect of the variables (induction 
temperature and induction duration, media composition, the optical density of the culture at the 
time of induction and Ca
2+
 concentration and inducer concentration. After the initial analysis, 
response surface methodology was used to examine the effects of the three variables (Ca
2+
 
concentration, inducer concentration and optical density of the culture at the time of induction. 
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5.3.5 Potential refolding experiments that may be attempted for prevention of the DcpA 
protein aggregation 
For proteins that tend to aggregate and misfold under all tested expression conditions, 
refolding of the protein from the insoluble fractions can be used to obtain the active form of the 
enzyme. In this method, the aggregated proteins are dissolved using denaturants such as 
guanidium hydrochloride or urea and then refolded using dilution, dialysis or column 
chromatography (Jobby et al., 2006). The D2 domain of Yersinia crystalline was overexpressed 
using E. coli as the host, and majority of the protein was expressed in the insoluble fraction. 
Active form of the domain was purified using refolding by column chromatography, and a 
method was developed to separate nucleic acids from co elution with the protein. The method 
developed led a rapid purification of the enzyme with a higher protein yield in comparison to that 
purified from the soluble fraction (Jobby et al., 2006).  
An alternative method of protein refolding to that of the traditional methods of dilution or 
dialysis is the matrix assisted refolding. A eukaryotic heat shock protein Hsp26 from 
Saccharomyces cerevisiae was expressed in E. coli BL21 (DE3) cells in the form of aggregates 
and then refolded to its active form using a matrix assisted refolding. The protein was refolded in 
an immobilized state (Franzmann 2006). Refolding of the protein from the insoluble fraction was 
also used in the biochemical characterization of the esterase EM2L8 from metagenomic library 
of uncultured microorganisms from deep sea sediments. The protein was expressed in the 
insoluble fraction in the E. coli hosts at an induction temperature of 37 ºC and in the soluble 
fraction at an induction temperature of 18 ºC. The insoluble fraction also exhibited enzymatic 
activity on gel during SDS-PAGE electrophoresis, suggesting that the protein was refolded 
during the electrophoresis. The insoluble fraction showed activity after denaturation with a 
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detergent followed by dilution that confirmed that the protein was refolded to the active form 
from the misfolded state (Park et al., 2007).  
Instead of using denaturants to solubilize the inclusion bodies, non denaturating agents 
can also be used for expression of protein in the soluble fraction. Non denaturing agents are 
particularly useful for the expression of proteins that tend to get expressed partly in the soluble 
and partly in the insoluble fraction. Partial expression into the insoluble fraction is due to slight 
misfolding in comparison to the native structure of the proteins and many protein families such 
as kinases, tumor necrosis factors, and interferon-gamma have been expressed partially in 
insoluble fraction (Tsumoto et al., 2010). Use of arginine as a non denaturing solubilization 
agent has prevent protein aggregation of a lot of proteins (Tsumoto et al., 2010). Inclusion body 
formation is also caused by the formation of the native like secondary protein structures in the 
expression host (Singh et al., 2005). In some cases, it has been shown that using a mild 
denaturing agent works better than stronger denaturants such as guanidium hydrochloride. A 
specific example of using a milder denaturing agent for preparation offunctionally active protein 
was seen in the case of the human growth hormone (Singh et al., 2005).  
The most recent success of protein refolding dehalogenases was observed in the 
functional expression of a vinyl chloride reductive dehalogenase in E. coli (Parthasarathy et al., 
2015). The vinyl chloride reductive dehalogenase gene was fused to an N-terminal maltose 
binding tag along with 6xhistidine tag and was expressed mostly in the insoluble fraction in E. 
coli BL21 (DE3) cells. The expressed protein was solubilized in 8M urea and purified using a 
Ni-IDA column. The purified proteins were then reduced by dithiothreitol and cofactor-
reconstituted and eluted with refolding buffer in the presence of cobalamin. The cofactor-
reconstituted and refolded protein showed functional dehalogenase activity. This appears to be a 
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promising approach for the functional expression of DcpA reductive dehalogenase and other 
putative reductive dehalogenases from D. lykanthroporepellens. 
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Appendix A: Results from Bioanalyzer tests to assess RNA quality 
 
 
  
Fig A1. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2,3-TCP (Replicates A, B, and C shown from top to bottom). 
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Fig A2. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following incubation with no solvent (controls in the 1,2,3-TCP experiment). Replicates A, B, 
and C shown from top to bottom. 
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Fig A3. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCP (Replicates A, B, and C shown from top to bottom). 
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Fig A4. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following incubation with no solvent (controls in the 1,2-DCP experiment) (Replicates A, B, and 
C shown from top to bottom). 
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Fig A5. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (Replicates A, B, and C shown from top to bottom). 
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Fig A6. Electropherogram results for RNA extracted from D. lykanthroporepellens BL-DC-9
T
 
following incubation with no solvent (controls in the 1,2-DCA experiment). Replicates A, B, and 
C shown from top to bottom.  
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Appendix B:  Gel images supporting results reported in Tables 2.6 and 2.4 (PCR 
amplicons from all solvent replicates run on the same gel for a single primer set)  
 
Fig B1. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0068 
(expected amplicon size 434 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B2. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0069 
(expected amplicon size 360 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B3. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0075 
(expected amplicon size 270 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
1     2    3    4     5     6    7    8      9   10   11   12 
1     2    3     4     5     6    7     8      9   10   11   12 
1    2   3   4   5   6  7   8   9   10   11  12 
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Fig B4. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0121 
(expected amplicon size 462 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B5. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_0156-Dhly_0157 (expected amplicon size 503 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B6. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0274 
(expected amplicon size 345 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
1     2    3     4     5     6    7     8    9   10   11   12 
1     2    3    4    5   6    7     8    9   10   11   12 
1     2    3    4    5   6    7     8    9   10   11   12 
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Fig B7. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_0275-Dhly_0276 (expected amplicon size 419 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B8. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0283 
(expected amplicon size 438 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B9. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0479 
(expected amplicon size 410 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
1     2     3    4      5    6     7      8    9    10   11   12 
   1     2    3    4    5    6    7    8    9   10   11   12 
1      2     3    4     5    6     7     8     9   10   11   12 
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Fig B10. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0849 
(expected amplicon size 372 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B11. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0910 
(expected amplicon size 244 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B12. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_1053-Dhly_1054 (expected amplicon size 608 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
1     2    3    4    5    6    7     8    9   10   11   12 
1    2   3   4   5   6    7   8   9   10   11 12 
   1   2    3   4   5   6    7    8   9  10 11  12 
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Fig B13. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1148 
(expected amplicon size 551 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B14. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_1151-Dhly_1152 (expected amplicon size 349 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B15. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1328 
(expected amplicon size 347 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
1       2    3    4      5    6     7     8     9    10   11   12 
1     2      3    4    5     6     7     8    9    10   11   12 
1    2   3   4    5    6   7    8    9  10  11  12 
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Fig B16. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1355 
(expected amplicon size 464 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B17. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1514 
(expected amplicon size 310 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B18. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1520 
(expected amplicon size 217 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
1     2    3    4    5   6    7    8   9   10  11  12 
  1    2   3  4   5  6   7     8  9   10    11 12 
1     2     3      4      5    6      7     8     9   10   11   12 
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Fig B19. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1523 
(expected amplicon size 892 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B20. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_1524-Dhly_1525 (expected amplicon size 168 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B21. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1530 
(expected amplicon size 196 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
1    2   3   4   5   6    7    8   9   10  11  12 
1     2    3     4     5     6     7     8     9    10   11   12 
1     2     3    4      5      6     7     8    9   10   11   12 
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Fig B22. Gel images showing amplicons from RT-PCR employing primers targeting rdhAB 
Dhly_1533-Dhly_1534 (expected amplicon size 677 bp) for D. lykanthroporepellens BL-DC-9
T
 
following growth on 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B23. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1540 
(expected amplicon size 387 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B24. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1541 
(expected amplicon size 115 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
  1     2     3    4     5     6      7     8    9   10    11   12 
1      2    3    4    5    6    7     8    9   10    11   12 
1    2     3    4    5     6     7    8     9    10   11   12 
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Fig B25. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1582 
(expected amplicon size 437 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B26. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0068 
(expected amplicon size 434 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B27. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0069 
(expected amplicon size 360 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
  1   2    3    4   5   6    7   8   9  10  11   12 
1     2    3    4    5   6    7    8    9   10   11   12 
1     2    3    4    5   6    7   8    9   10  11   12 
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Fig B28. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0075 
(expected amplicon size 270 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B29. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0121 
(expected amplicon size 462 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig B30. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0156-
Dehly_0157 (expected amplicon size 503 bp) for D. lykanthroporepellens BL-DC-9
T
 following 
growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
1    2   3    4    5   6    7    8    9   10   11   12 
1     2    3    4    5   6    7     8    9   10   11   12 
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Fig B31. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0274 
(expected amplicon size 345 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig B32. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0275-
Dehly 0276 (expected amplicon size 419 bp) for D. lykanthroporepellens BL-DC-9
T
 following 
growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
1     2    3    4    5   6    7     8    9   10   11   12 
1     2    3    4    5   6    7     8    9   10   11   12 
1      2     3    4    5    6    7     8    9   10    11   12 
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Fig B33. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0283 
(expected amplicon size 438 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B34. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0479 
(expected amplicon size 410 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B35. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0849 
(expected amplicon size 372 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
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Fig B36. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0910 
(expected amplicon size 244 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig B37. Gel images showing amplicons from RT-PCR employing primers targeting 
Dhly_1054_Dehly_1053 (expected amplicon size 608 bp) for D. lykanthroporepellens BL-DC-
9
T
 following growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP 
(lanes 8-10). Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B38. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1148 
(expected amplicon size 551 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
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Fig B39. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1151-
Dehly-1152 (expected amplicon size 349 bp) for D. lykanthroporepellens BL-DC-9
T
 following 
growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B40. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1328 
(expected amplicon size 347 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B41. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1355 
(expected amplicon size 464 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
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Fig B42. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1514 
(expected amplicon size 310 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig B43. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1520 
(expected amplicon size 217 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig B44. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1523 
(expected amplicon size 892 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
1      2    3    4      5    6     7     8     9   10    11   12 
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absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B45. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1524-
Dehly_1525 (expected amplicon size 168 bp) for D. lykanthroporepellens BL-DC-9
T
 following 
growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B46. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1530 
(expected amplicon size 196 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B47. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1533-
Dehly_1534 (expected amplicon size 677 bp) for D. lykanthroporepellens BL-DC-9
T
 following 
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growth in absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). 
Lane 1: marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B48. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1540 
(expected amplicon size 387 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B49. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1541 
(expected amplicon size 115 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
Fig B50. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1582 
(expected amplicon size 437 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
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Appendix C:  Gel images supporting results reported in Tables 2.5 (PCR products all 
solvent replicates run on the same gel for a single primer set)  
 
 
Fig C1. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0120 
(expected amplicon size 225 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 12 positive control. Lane 11 negative control. 
 
Fig C2. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_0270 
(expected amplicon size 143 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 12 positive control. Lane 11 negative control. 
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Fig C3. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1149 
(expected amplicon size 622 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 12 positive control. Lane 11 negative control. 
 
Fig C4. Gel images showing amplicons from RT-PCR employing primers targeting Dhly_1531 
(expected amplicon size 185 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth on 
1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: marker (100 bp 
Sigma). Lane 12 positive control. Lane 11 negative control. 
 
Fig C5. Gel images showing amplicons from RT-PCR employing primers targeting Dehly_0120 
(expected amplicon size 225 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 12 positive control. Lane 11 negative control. 
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Fig C6. Gel images showing amplicons from RT-PCR employing primers targeting Dehly_0270 
(expected amplicon size 143 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 11 positive control. Lane 12 negative control. 
 
 
Fig C7. Gel images showing amplicons from RT-PCR employing primers targeting Dehly_1149 
(expected amplicon size 622 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 12 positive control. Lane 11 negative control. 
 
 
Fig C8. Gel images showing amplicons from RT-PCR employing primers targeting Dehly_1531 
(expected amplicon size 185 bp) for D. lykanthroporepellens BL-DC-9
T
 following growth in 
absence of 1,2-DCA (lanes 2-4), 1,2-DCP (lanes 5-7), and 1,2,3-TCP (lanes 8-10). Lane 1: 
marker (100 bp Sigma). Lane 12 positive control. Lane 11 negative control. 
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Appendix D1:  Gel images supporting results reported in chapter 3 
 
 
Fig D1. SDS PAGE analysis of transformed E. coli induced at different temperatures. Lanes 2, 3 
and 6: the lysates from cells induced at temperatures of 18 °C (lane 2), 23 °C (lane 3), and 37°C 
(lane 6). Lanes 1, 4 & 5: the soluble fractions recovered from cells induced at temperatures of 18 
°C (lane 1), 23 °C (lane 4), and 37°C (lane 5).  Lane 7: Precision Plus protein standard (BioRad). 
1                  2                  3                4                5                 6              7      
53kD 
10kD 
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Fig D2. SDS PAGE analysis of the transformed E. coli cells induced for different time intervals. 
Lanes 2, 4, 6 and 8: cell lysate generated after induction for 0.5 hours (lane 2), 1 Hour (lane 4), 
1.5 Hour (lane 6) and 2 hours (lane 8). Lanes 3, 5, 7 and 9: soluble fractions of cell lysate 
recovered from cells induced for 0.5 Hour (lanes 3), 1 hour (lane 5), 1.5 Hours (lane 7) and 2 
hours (lane 9). Lane 1: Precision Plus protein standard (BioRad).  
.  
Fig D3. SDS PAGE analysis of the transformed E. coli cells that were induced at different IPTG 
concentrations. Lanes 2, 4, and 6: cell lysate generated at IPTG concentration 0.2 mM (lane 2), 
0.4 mM (lane 4) and 0.6 mM (lane 6). Lanes 3, 5 and 7: soluble fractions of the cell lysate 
recovered at IPTG concentration 0.2 mM (lane 3), 0.4 mM (lane 5) and 0.6 mM (lane 7). Lane 1: 
Precision Plus protein standard (BioRad). 
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Appendix D2: Gene sequence for synthesis and expression in E. coli 
Vector Map of pET16b (Novagen) 
 
Original Gene Sequence before Modification 
 
The part of the sequence highlited in red is the TAT signal sequence 
>gb|CP002084.1|:1496492-1497940 Dehalogenimonas lykanthroporepellens BL-DC-9, 
complete genome 
GAATTC  
ATGAAATCGCATTCCACAATGAGTCGCCGAGATTTTATGAAGACCCTAGGTTTGGGTGCAACAGCCATTG 
GTAGTGTAGGTGTCACCGCTCCCATTTTCCATGATCTCGACGAAATGATGAGCATAAGTGCTGCCGAAAC 
TTTTAACTCCACTACATCCATGCAAAAACGTCCTTGGTGGGTTAAAGAGGTTGACATTCCTACAGTAGAA 
ATCGACTTGAAACTACGTACCCCCTATGCGGGCCATCTATCTGCTGGTTTGTCTCCTCTATATCTTTCTA 
AAGAGGAGATTGCTGCCATCCTGGCTTCTCAACAGAACAATGCTATTGAAGGAGCTAAAAACAACCGGCC 
AGGTTTTACATTGCGTGATCAAATTGGAGCCTGGGCCTCGTTAGATAGAGGACAAACGGGATATGTGAAA 
TATCCGCCTGAAGGTTTTCGAACAATAAAAGTTACTCATGAAACTTTAGGTGTACCGAAGTGGGAAGGCT 
CCGAAACGGAAAACGCATTCATGATTCGAACTTTCCTGAGGCAATTTGGTGCGGGGGCGATTGGCTATGC 
AAGAGTGGATGACGACAGCGTCGGACCACGTAAACCCCTTTTTAACACTCATGTAAGATTGGAGAACAAC 
CCAGATTACAAGTATGACGCTAATGGTACATTCGTCATGCCAGAAAAGTGCAAGTATGCCATCATAATTT 
ATGATAGAAGTCCCCGAGATCCTAACAACTATCGTCGTACCGTCAACAGCCCTCAAGCCTTTGTATCAAA 
TATGGAGAAATGTGAGTATGGTCATAAGCTTCAAAACTTCCTTTGGGGTTTAGGCTACCAATCTTATTGG 
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TTTGAAGATGGCACAACAAGCAAATTCACCGGGACTCCGACGAATGTTTGGGGTATCCTCTCAGGCATAG 
GCGAATACACCCGAATTCACAATCCGGTCTCGCAACCCGAAGGTGAGACCGGTAATTTTGCCAGTATTCT 
CTTCACAGATTTGCCTCTACCTACTACTAAACCGATAGACTTTGGAGCTTTAGAATTCTGTAAAACTTGT 
GGGATATGTGCCGACGTTTGCCCAGCCGGAGCAATTCCTACAGTAGAAGAGTATAGAGAGCCAACTTGGG 
ATCGAGCAACTGGTCCCTGGAGTGCTTCCAATGACCATAAAGGATATCCTAATAAATCCATTGAATGCGT 
AAAGTGGTATTTTTCTAATGCAGTTACAGCCTTCGCTCCTGCCTCTCGCCCAGTTGGTGTGTGTCGTCGA 
TGTTCCAGCCATTGTGTCTTTAGTAAAGATCATAAAGCTTGGATTCATGAAGTAGTTAAGGGTGTAGTGT 
CCACTACTCCTGTGATGAACAGCTTCTTTACTAAAATGGATACGCTATCCGGTTACAGTGACGTCATCTC 
AGATGAAGGCAGGGCTGAATATTGGCACCAGTACCTGCCCGCTATTTAA 
GGATCC 
 
Optimized Sequence 
 (Optimized Sequence Length:1419, GC%:51.92) 
CATATG 
ACGCTGGGCCTGGGTGCCACGGCGATTGGTTCAGTTGGTGTTACGGCTCCGATCTTTCACGACCTGGACGAAATG 
ATGAGTATCTCCGCGGCCGAAACCTTTAACTCAACCACGTCGATGCAGAAACGCCCGTGGTGGGTGAAAGAAGTT 
GACATCCCGACGGTGGAAATTGATCTGAAACTGCGTACCCCGTATGCTGGCCATCTGAGTGCGGGTCTGTCCCCG 
CTGTACCTGAGCAAAGAAGAAATCGCAGCTATTCTGGCGTCTCAGCAAAACAATGCCATCGAAGGCGCAAAAAAC 
AATCGTCCGGGTTTTACCCTGCGTGACCAGATTGGTGCCTGGGCAAGCCTGGATCGTGGTCAAACGGGTTATGTG 
AAATACCCGCCGGAAGGTTTTCGTACCATCAAAGTTACGCATGAAACCCTGGGCGTCCCGAAATGGGAAGGTTCA 
GAAACGGAAAATGCTTTCATGATCCGTACCTTTCTGCGCCAGTTCGGCGCAGGTGCTATTGGCTATGCGCGTGTC 
GATGACGATTCTGTGGGTCCGCGCAAACCGCTGTTTAACACGCACGTGCGTCTGGAAAACAATCCGGACTATAAA 
TACGATGCCAATGGCACCTTCGTTATGCCGGAAAAATGTAAATACGCAATCATCATCTACGACCGTAGTCCGCGC 
GATCCGAACAATTATCGTCGCACCGTGAACTCACCGCAGGCCTTTGTTTCGAATATGGAAAAATGCGAATACGGT 
CATAAACTGCAGAACTTCCTGTGGGGCCTGGGTTATCAAAGTTACTGGTTTGAAGATGGCACCACGTCCAAATTC 
ACCGGTACGCCGACCAATGTCTGGGGCATCCTGAGCGGCATTGGTGAATATACCCGCATTCACAACCCTGTTAGT 
CAACCGGAAGGCGAAACGGGTAATTTTGCGTCCATCCTGTTCACCGACCTGCCGCTGCCGACCACGAAACCGATT 
GATTTTGGTGCTCTGGAATTCTGCAAAACGTGTGGCATCTGCGCGGATGTTTGTCCGGCGGGTGCCATTCCGACC 
GTCGAAGAATACCGTGAACCGACCTGGGACCGTGCAACCGGTCCGTGGAGTGCATCCAACGATCATAAAGGTTAC 
CCGAACAAATCAATCGAATGTGTCAAATGGTACTTTTCGAATGCGGTGACCGCATTTGCTCCGGCCTCACGTCCG 
GTTGGCGTCTGTCGTCGCTGCAGCTCTCACTGCGTGTTTTCGAAAGACCATAAAGCATGGATTCACGAAGTGGTT 
AAAGGCGTCGTGAGCACCACGCCGGTTATGAACAGCTTTTTCACGAAAATGGATACCCTGAGCGGTTATTCTGAT 
GTGATTAGCGATGAAGGTCGTGCGGAATACTGGCACCAATATCTGCCGGCGATTTGA 
GGATCC 
DNA Alignment (Optimized Region) 
 
Optimized 7     ACGCTGGGCCTGGGTGCCACGGCGATTGGTTCAGTTGGTGTTACGGCTCCGATCTTTCAC 
Original  7     ACCCTAGGTTTGGGTGCAACAGCCATTGGTAGTGTAGGTGTCACCGCTCCCATTTTCCAT 
 
Optimized 67    GACCTGGACGAAATGATGAGTATCTCCGCGGCCGAAACCTTTAACTCAACCACGTCGATG 
Original 67     GATCTCGACGAAATGATGAGCATAAGTGCTGCCGAAACTTTTAACTCCACTACATCCATG 
 
Optimized 127   CAGAAACGCCCGTGGTGGGTGAAAGAAGTTGACATCCCGACGGTGGAAATTGATCTGAAA 
Original 127    CAAAAACGTCCTTGGTGGGTTAAAGAGGTTGACATTCCTACAGTAGAAATCGACTTGAAA 
 
Optimized 187   CTGCGTACCCCGTATGCTGGCCATCTGAGTGCGGGTCTGTCCCCGCTGTACCTGAGCAAA 
Original 187    CTACGTACCCCCTATGCGGGCCATCTATCTGCTGGTTTGTCTCCTCTATATCTTTCTAAA 
 
Optimized 247   GAAGAAATCGCAGCTATTCTGGCGTCTCAGCAAAACAATGCCATCGAAGGCGCAAAAAAC 
Original 247    GAGGAGATTGCTGCCATCCTGGCTTCTCAACAGAACAATGCTATTGAAGGAGCTAAAAAC 
Optimized 307   AATCGTCCGGGTTTTACCCTGCGTGACCAGATTGGTGCCTGGGCAAGCCTGGATCGTGGT 
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Original 307    AACCGGCCAGGTTTTACATTGCGTGATCAAATTGGAGCCTGGGCCTCGTTAGATAGAGGA 
 
Optimized 367   CAAACGGGTTATGTGAAATACCCGCCGGAAGGTTTTCGTACCATCAAAGTTACGCATGAA 
Original 367    CAAACGGGATATGTGAAATATCCGCCTGAAGGTTTTCGAACAATAAAAGTTACTCATGAA 
 
Optimized 427   ACCCTGGGCGTCCCGAAATGGGAAGGTTCAGAAACGGAAAATGCTTTCATGATCCGTACC 
Original 427    ACTTTAGGTGTACCGAAGTGGGAAGGCTCCGAAACGGAAAACGCATTCATGATTCGAACT 
 
Optimized 487   TTTCTGCGCCAGTTCGGCGCAGGTGCTATTGGCTATGCGCGTGTCGATGACGATTCTGTG 
Original 487    TTCCTGAGGCAATTTGGTGCGGGGGCGATTGGCTATGCAAGAGTGGATGACGACAGCGTC 
 
Optimized 547   GGTCCGCGCAAACCGCTGTTTAACACGCACGTGCGTCTGGAAAACAATCCGGACTATAAA 
Original 547    GGACCACGTAAACCCCTTTTTAACACTCATGTAAGATTGGAGAACAACCCAGATTACAAG 
 
Optimized 607   TACGATGCCAATGGCACCTTCGTTATGCCGGAAAAATGTAAATACGCAATCATCATCTAC 
Original 607    TATGACGCTAATGGTACATTCGTCATGCCAGAAAAGTGCAAGTATGCCATCATAATTTAT 
 
Optimized 667   GACCGTAGTCCGCGCGATCCGAACAATTATCGTCGCACCGTGAACTCACCGCAGGCCTTT 
Original 667    GATAGAAGTCCCCGAGATCCTAACAACTATCGTCGTACCGTCAACAGCCCTCAAGCCTTT 
 
Optimized 727   GTTTCGAATATGGAAAAATGCGAATACGGTCATAAACTGCAGAACTTCCTGTGGGGCCTG 
Original 727    GTATCAAATATGGAGAAATGTGAGTATGGTCATAAGCTTCAAAACTTCCTTTGGGGTTTA 
 
Optimized 787   GGTTATCAAAGTTACTGGTTTGAAGATGGCACCACGTCCAAATTCACCGGTACGCCGACC 
Original 787    GGCTACCAATCTTATTGGTTTGAAGATGGCACAACAAGCAAATTCACCGGGACTCCGACG 
 
Optimized 847   AATGTCTGGGGCATCCTGAGCGGCATTGGTGAATATACCCGCATTCACAACCCTGTTAGT 
Original 847    AATGTTTGGGGTATCCTCTCAGGCATAGGCGAATACACCCGAATTCACAATCCGGTCTCG 
 
Optimized 907   CAACCGGAAGGCGAAACGGGTAATTTTGCGTCCATCCTGTTCACCGACCTGCCGCTGCCG 
Original 907    CAACCCGAAGGTGAGACCGGTAATTTTGCCAGTATTCTCTTCACAGATTTGCCTCTACCT 
 
Optimized 967   ACCACGAAACCGATTGATTTTGGTGCTCTGGAATTCTGCAAAACGTGTGGCATCTGCGCG 
Original 967    ACTACTAAACCGATAGACTTTGGAGCTTTAGAATTCTGTAAAACTTGTGGGATATGTGCC 
 
Optimized 1027  GATGTTTGTCCGGCGGGTGCCATTCCGACCGTCGAAGAATACCGTGAACCGACCTGGGAC 
Original 1027   GACGTTTGCCCAGCCGGAGCAATTCCTACAGTAGAAGAGTATAGAGAGCCAACTTGGGAT 
Optimized 1087  CGTGCAACCGGTCCGTGGAGTGCATCCAACGATCATAAAGGTTACCCGAACAAATCAATC 
Original 1087   CGAGCAACTGGTCCCTGGAGTGCTTCCAATGACCATAAAGGATATCCTAATAAATCCATT 
 
Optimized 1147  GAATGTGTCAAATGGTACTTTTCGAATGCGGTGACCGCATTTGCTCCGGCCTCACGTCCG 
Original 1147   GAATGCGTAAAGTGGTATTTTTCTAATGCAGTTACAGCCTTCGCTCCTGCCTCTCGCCCA 
 
Optimized 1207  GTTGGCGTCTGTCGTCGCTGCAGCTCTCACTGCGTGTTTTCGAAAGACCATAAAGCATGG 
Original 1207   GTTGGTGTGTGTCGTCGATGTTCCAGCCATTGTGTCTTTAGTAAAGATCATAAAGCTTGG 
 
Optimized 1267  ATTCACGAAGTGGTTAAAGGCGTCGTGAGCACCACGCCGGTTATGAACAGCTTTTTCACG 
Original 1267   ATTCATGAAGTAGTTAAGGGTGTAGTGTCCACTACTCCTGTGATGAACAGCTTCTTTACT 
 
Optimized 1327  AAAATGGATACCCTGAGCGGTTATTCTGATGTGATTAGCGATGAAGGTCGTGCGGAATAC 
Original 1327   AAAATGGATACGCTATCCGGTTACAGTGACGTCATCTCAGATGAAGGCAGGGCTGAATAT 
 
Optimized 1387  TGGCACCAATATCTGCCGGCGATTTGA 
Original 1387   TGGCACCAGTACCTGCCCGCTATTTAA 
 
Protein Alignment (Optimized Region) 
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Optimized 1   TLGLGATAIGSVGVTAPIFHDLDEMMSISAAETFNSTTSMQKRPWWVKEVDIPTVEIDLK 
Original 1    TLGLGATAIGSVGVTAPIFHDLDEMMSISAAETFNSTTSMQKRPWWVKEVDIPTVEIDLK 
 
Optimized 61  LRTPYAGHLSAGLSPLYLSKEEIAAILASQQNNAIEGAKNNRPGFTLRDQIGAWASLDRG 
Original 61   LRTPYAGHLSAGLSPLYLSKEEIAAILASQQNNAIEGAKNNRPGFTLRDQIGAWASLDRG 
 
Optimized 121 QTGYVKYPPEGFRTIKVTHETLGVPKWEGSETENAFMIRTFLRQFGAGAIGYARVDDDSV 
Original 121  QTGYVKYPPEGFRTIKVTHETLGVPKWEGSETENAFMIRTFLRQFGAGAIGYARVDDDSV 
 
Optimized 181 GPRKPLFNTHVRLENNPDYKYDANGTFVMPEKCKYAIIIYDRSPRDPNNYRRTVNSPQAF 
Original 181  GPRKPLFNTHVRLENNPDYKYDANGTFVMPEKCKYAIIIYDRSPRDPNNYRRTVNSPQAF 
 
Optimized 241 VSNMEKCEYGHKLQNFLWGLGYQSYWFEDGTTSKFTGTPTNVWGILSGIGEYTRIHNPVS 
Original 241  VSNMEKCEYGHKLQNFLWGLGYQSYWFEDGTTSKFTGTPTNVWGILSGIGEYTRIHNPVS 
Optimized 301 QPEGETGNFASILFTDLPLPTTKPIDFGALEFCKTCGICADVCPAGAIPTVEEYREPTWD 
Original 301  QPEGETGNFASILFTDLPLPTTKPIDFGALEFCKTCGICADVCPAGAIPTVEEYREPTWD 
 
Optimized 361 RATGPWSASNDHKGYPNKSIECVKWYFSNAVTAFAPASRPVGVCRRCSSHCVFSKDHKAW 
Original 361  RATGPWSASNDHKGYPNKSIECVKWYFSNAVTAFAPASRPVGVCRRCSSHCVFSKDHKAW 
 
Optimized 421 IHEVVKGVVSTTPVMNSFFTKMDTLSGYSDVISDEGRAEYWHQYLPAI* 
Original 421  IHEVVKGVVSTTPVMNSFFTKMDTLSGYSDVISDEGRAEYWHQYLPAI* 
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Appendix E1:  Gel images supporting results reported in chapter 4 
 
 
 Fig E1. SDS PAGE analysis of the transformed S. blattae cells (co-transformed with 
Dehly_1524 and PceT). Lanes 4 and 6: cell lysate from anhydrotetracyclin induced S. blattae 
cells induced for 8 hours. Lanes 3 and 5: cell lysate generated from uninduced S. blattae cells 
grown under identical conditions. Lanes 1 and 2: soluble fraction of cell lysate recovered from 
anhydrotetracyclin induced S. blattae cells induced for 8 hours SDS-PAGE analysis was 
repeated to check for expression of the protein used for checking dehalogenase activity. Lane M: 
Precision Plus protein standard (BioRad). 
.  
Fig E2. SDS PAGE analysis of the transformed S. blattae cells at lower induction concentration 
of 10 ng/mL anhydrotetracycline. Lanes 9, 6 and 3: cell lysate generated after induction for 7 
Hours (lane 9), 5 hours (lane 6) and 3 Hours (lane 3). Lanes 1, 2, 4, 5, 7 and 8 are the soluble 
fractions of cell lysate recovered from cells induced for 3 Hours (lanes 1 and 2), 5 Hours (lanes 4 
and 5) and 7 Hours (lanes 7 and 8). Lane M: Precision Plus protein standard (BioRad). 
53kD 
10kD 
250kD     1              2              3                4               5              6            M                      
53 kDa 
10kD 
250 kDa    1          2          3         4          5           6           7           8         9          M 
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Appendix E2: Gene sequence for synthesis and expression in S.blattae 
 
Vector Map of pASK-IBA 37 plus( IBA -Germany) 
 
Vector Map of pASK-IBA 3C(IBA-Germany) 
 
 Original Gene Sequence before Modification 
The part of the sequence highlighted in red is the TAT signal sequence 
>gb|CP002084.1|:1496492-1497940 Dehalogenimonas lykanthroporepellens BL-DC-9, 
complete genome 
 
ATGAAATCGCATTCCACAATGAGTCGCCGAGATTTTATGAAGACCCTAGGTTTGGGTGCAACAGCCATTGGTAGTGT
AGGTGTCACCGCTCCCATTTTCCATGATCTCGACGAAATGATGAGCATAAGTGCTGCCGAAAC 
TTTTAACTCCACTACATCCATGCAAAAACGTCCTTGGTGGGTTAAAGAGGTTGACATTCCTACAGTAGAA 
ATCGACTTGAAACTACGTACCCCCTATGCGGGCCATCTATCTGCTGGTTTGTCTCCTCTATATCTTTCTA 
AAGAGGAGATTGCTGCCATCCTGGCTTCTCAACAGAACAATGCTATTGAAGGAGCTAAAAACAACCGGCC 
AGGTTTTACATTGCGTGATCAAATTGGAGCCTGGGCCTCGTTAGATAGAGGACAAACGGGATATGTGAAA 
TATCCGCCTGAAGGTTTTCGAACAATAAAAGTTACTCATGAAACTTTAGGTGTACCGAAGTGGGAAGGCT 
CCGAAACGGAAAACGCATTCATGATTCGAACTTTCCTGAGGCAATTTGGTGCGGGGGCGATTGGCTATGC 
 140 
 
AAGAGTGGATGACGACAGCGTCGGACCACGTAAACCCCTTTTTAACACTCATGTAAGATTGGAGAACAAC 
CCAGATTACAAGTATGACGCTAATGGTACATTCGTCATGCCAGAAAAGTGCAAGTATGCCATCATAATTT 
ATGATAGAAGTCCCCGAGATCCTAACAACTATCGTCGTACCGTCAACAGCCCTCAAGCCTTTGTATCAAA 
TATGGAGAAATGTGAGTATGGTCATAAGCTTCAAAACTTCCTTTGGGGTTTAGGCTACCAATCTTATTGG 
TTTGAAGATGGCACAACAAGCAAATTCACCGGGACTCCGACGAATGTTTGGGGTATCCTCTCAGGCATAG 
GCGAATACACCCGAATTCACAATCCGGTCTCGCAACCCGAAGGTGAGACCGGTAATTTTGCCAGTATTCT 
CTTCACAGATTTGCCTCTACCTACTACTAAACCGATAGACTTTGGAGCTTTAGAATTCTGTAAAACTTGT 
GGGATATGTGCCGACGTTTGCCCAGCCGGAGCAATTCCTACAGTAGAAGAGTATAGAGAGCCAACTTGGG 
ATCGAGCAACTGGTCCCTGGAGTGCTTCCAATGACCATAAAGGATATCCTAATAAATCCATTGAATGCGT 
AAAGTGGTATTTTTCTAATGCAGTTACAGCCTTCGCTCCTGCCTCTCGCCCAGTTGGTGTGTGTCGTCGA 
TGTTCCAGCCATTGTGTCTTTAGTAAAGATCATAAAGCTTGGATTCATGAAGTAGTTAAGGGTGTAGTGT 
CCACTACTCCTGTGATGAACAGCTTCTTTACTAAAATGGATACGCTATCCGGTTACAGTGACGTCATCTC 
AGATGAAGGCAGGGCTGAATATTGGCACCAGTACCTGCCCGCTATTTAA 
Gene Sequence synthesized for subcloning along with the restriction sites 
Sequence: 
GAATTC 
ATGAAATCGCATTCCACAATGAGTCGCCGAGATTTTATGAAGACCCTAGGTTTGGGTGCAACAGCCATTGGTAGTGT
AGGTGTCACCGCTCCCATTTTCCATGATCTCGACGAAATGATGAGCATAAGTGCTGCCGAAACTTTTAACTCCACTA
CATCCATGCAAAAACGTCCTTGGTGGGTTAAAGAGGTTGACATTCCTACAGTAGAAATCGACTTGAAACTACGTACC
CCCTATGCGGGCCATCTATCTGCTGGTTTGTCTCCTCTATATCTTTCTAAAGAGGAGATTGCTGCCATCCTGGCTTC
TCAACAGAACAATGCTATTGAAGGAGCTAAAAACAACCGGCCAGGTTTTACATTGCGTGATCAAATTGGAGCCTGGG
CCTCGTTAGATAGAGGACAAACGGGATATGTGAAATATCCGCCTGAAGGTTTTCGAACAATAAAAGTTACTCATGAA
ACTTTAGGTGTACCGAAGTGGGAAGGCTCCGAAACGGAAAACGCATTCATGATTCGAACTTTCCTGAGGCAATTTGG
TGCGGGGGCGATTGGCTATGCAAGAGTGGATGACGACAGCGTCGGACCACGTAAACCCCTTTTTAACACTCATGTAA
GATTGGAGAACAACCCAGATTACAAGTATGACGCTAATGGTACATTCGTCATGCCAGAAAAGTGCAAGTATGCCATC
ATAATTTATGATAGAAGTCCCCGAGATCCTAACAACTATCGTCGTACCGTCAACAGCCCTCAAGCCTTTGTATCAAA
TATGGAGAAATGTGAGTATGGTCATAAGCTTCAAAACTTCCTTTGGGGTTTAGGCTACCAATCTTATTGGTTTGAAG
ATGGCACAACAAGCAAATTCACCGGGACTCCGACGAATGTTTGGGGTATCCTCTCAGGCATAGGCGAATACACCCGA
ATTCACAATCCGGTCTCGCAACCCGAAGGTGAGACCGGTAATTTTGCCAGTATTCTCTTCACAGATTTGCCTCTACC
TACTACTAAACCGATAGACTTTGGAGCTTTAGAATTCTGTAAAACTTGTGGGATATGTGCCGACGTTTGCCCAGCCG
GAGCAATTCCTACAGTAGAAGAGTATAGAGAGCCAACTTGGGATCGAGCAACTGGTCCCTGGAGTGCTTCCAATGAC
CATAAAGGATATCCTAATAAATCCATTGAATGCGTAAAGTGGTATTTTTCTAATGCAGTTACAGCCTTCGCTCCTGC
CTCTCGCCCAGTTGGTGTGTGTCGTCGATGTTCCAGCCATTGTGTCTTTAGTAAAGATCATAAAGCTTGGATTCATG
AAGTAGTTAAGGGTGTAGTGTCCACTACTCCTGTGATGAACAGCTTCTTTACTAAAATGGATACGCTATCCGGTTAC
AGTGACGTCATCTCAGATGAAGGCAGGGCTGAATATTGGCACCAGTACCTGCCCGCTATTTAA         
GGATCC 
 
 
 
PceT gene from D. hafniense strain Y51 
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GAATTC 
ATGATAATGAAGCAGTTCGAACTTGGACAATATAAGGGTCTAAATGTGAAGCGTTTTGATACAACAGTCCAAGAAGA
GGAGATTCAGCAAGCCTTAGATTATATCATAGGCTCTTTTGATGAAATTGAAGAAGAAAAAAGAAATGAGCCTATTA
AAACAAACGATTATGTAATCGTGGATATTGACGGTTATGAAAAGGATGCAACAGTACCGGTTATAAGAAACATCGAT
ACAAAATTAATAGTCGGCAGTGAAGGTGTATTTCGAGAAGTTAGTGCAAATCTCCTAGGGAAGAAAATGGGCGACAC
AGTGACCTTTGAGACTGTTATTCAGCCCGATGCCTTAGAATTTCAGCGTTGGTGGGGAAGCGAGTTTACATTTACCG
TTAAGATTAAGAGCGTTTTTGTGGTGAAGAAACCAGAATTGACTGAAGAATTAATTAGGAAAGTTGAACCTGATCTA
AAAAACCTGAAAGACTTAAAAAATATGCTTGCCCTAAAAATCACTCACGAAAAAGAGGGGAAGGAACGGGAGGCAAA
TATTCTCTTGATTTTTCAAGCTTTAGTTAAACAATGTAAGTATGAATTTGATGAAGAAGAATTGGATTCAGCTGCTG
AAGATTTATATAAGAAATTTACTGAAGAACTCAAAATAGTTGATGATATGGAACTTATGGAATATTTGATCCATAGA
AAAATAACCGCAGACCAATTGCTGGCCGAATGTAAGGAAGAGGCATCCAGAAGGATTCTCTGGGAACTTATGATAAA
TTCTGTTATTGAGAAAGAAGAGATAAATCTTACTCCGGATGAAATCAAATATCTTGAAAAGCGAATTAACGAAAGCC
GACAAAACGGTCAACTCCCCGAAGAGTTTATGGACATCAATTTTTTACTGGCATCGTATTTACGAAAAAAAACAATA
GACTATTTGCTAAAAATCAATTTGGCAAGTTAG 
GGATCC 
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